Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review
Open accessAbstract
Objective: To consolidate evidence from systematic reviews and meta-analyses investigating the association between reproductive factors in women of reproductive age and their subsequent risk of cardiovascular disease. Design: Umbrella review. Data sources: Medline, Embase, and Cochrane databases for systematic reviews and meta-analyses from inception until 31 August 2019. Review methods: Two independent reviewers undertook screening, data extraction, and quality appraisal. The population was women of reproductive age. Exposures were fertility related factors and adverse pregnancy outcomes. Outcome was cardiovascular diseases in women, including ischaemic heart disease, heart failure, peripheral arterial disease, and stroke. Results: 32 reviews were included, evaluating multiple risk factors over an average follow-up period of 7-10 years. All except three reviews were of moderate quality. A narrative evidence synthesis with forest plots and tabular presentations was performed. Associations for composite cardiovascular disease were: twofold for pre-eclampsia, stillbirth, and preterm birth; 1.5-1.9-fold for gestational hypertension, placental abruption, gestational diabetes, and premature ovarian insufficiency; and less than 1.5-fold for early menarche, polycystic ovary syndrome, ever parity, and early menopause. A longer length of breastfeeding was associated with a reduced risk of cardiovascular disease. The associations for ischaemic heart disease were twofold or greater for pre-eclampsia, recurrent pre-eclampsia, gestational diabetes, and preterm birth; 1.5-1.9-fold for current use of combined oral contraceptives (oestrogen and progesterone), recurrent miscarriage, premature ovarian insufficiency, and early menopause; and less than 1.5-fold for miscarriage, polycystic ovary syndrome, and menopausal symptoms. For stroke outcomes, the associations were twofold or more for current use of any oral contraceptive (combined oral contraceptives or progesterone only pill), pre-eclampsia, and recurrent pre-eclampsia; 1.5-1.9-fold for current use of combined oral contraceptives, gestational diabetes, and preterm birth; and less than 1.5-fold for polycystic ovary syndrome. The association for heart failure was fourfold for pre-eclampsia. No association was found between cardiovascular disease outcomes and current use of progesterone only contraceptives, use of non-oral hormonal contraceptive agents, or fertility treatment. Conclusions: From menarche to menopause, reproductive factors were associated with cardiovascular disease in women. In this review, presenting absolute numbers on the scale of the problem was not feasible; however, if these associations are causal, they could account for a large proportion of unexplained risk of cardiovascular disease in women, and the risk might be modifiable. Identifying reproductive risk factors at an early stage in the life of women might facilitate the initiation of strategies to modify potential risks. Policy makers should consider incorporating reproductive risk factors as part of the assessment of cardiovascular risk in clinical guidelines. Systematic review registration: PROSPERO CRD42019120076.
AI snapshot
Written from the paper’s full text.
TL;DR
This umbrella review consolidates systematic reviews and meta-analyses on reproductive factors in women of reproductive age and later cardiovascular disease. It reports that multiple fertility-related factors and adverse pregnancy outcomes are associated with increased cardiovascular risk, while longer breastfeeding is associated with reduced risk.
Key findings
- Among 32 included reviews, composite cardiovascular disease associations were twofold for pre-eclampsia, stillbirth, and preterm birth; 1.5-1.9-fold for gestational hypertension, placental abruption, gestational diabetes, and premature ovarian insufficiency; and less than 1.5-fold for early menarche, polycystic ovary syndrome, ever parity, and early menopause. Longer breastfeeding was associated with reduced cardiovascular disease risk.
- For ischaemic heart disease, associations were twofold or greater for pre-eclampsia, recurrent pre-eclampsia, gestational diabetes, and preterm birth; 1.5-1.9-fold for current combined oral contraceptive use, recurrent miscarriage, premature ovarian insufficiency, and early menopause; and less than 1.5-fold for miscarriage, polycystic ovary syndrome, and menopausal symptoms.
- For stroke, associations were twofold or more for current use of any oral contraceptive, pre-eclampsia, and recurrent pre-eclampsia; 1.5-1.9-fold for current combined oral contraceptive use, gestational diabetes, and preterm birth; and less than 1.5-fold for polycystic ovary syndrome. Pre-eclampsia was associated with a fourfold risk of heart failure.
- No association was found between cardiovascular disease outcomes and current use of progesterone only contraceptives, use of non-oral hormonal contraceptive agents, or fertility treatment.
Methods
- Umbrella review of systematic reviews and meta-analyses; population was women of reproductive age; exposures were fertility-related factors and adverse pregnancy outcomes; outcomes included ischaemic heart disease, heart failure, peripheral arterial disease, stroke, and composite cardiovascular disease.
- Medline, Embase, and Cochrane databases were searched from inception until 31 August 2019; PRISMA guidelines were followed and the protocol was registered in PROSPERO (CRD42019120076).
- Two reviewers independently screened, extracted data, and appraised quality with AMSTAR 2; overlapping reviews were assessed with corrected covered area, outdated reviews were excluded, and findings were synthesised narratively with forest plots and tables.
Limitations
- The paper states that missing metadata, including participant and event numbers, hindered reporting; systematic reviews on endometriosis, pelvic inflammatory disease, first trimester bleeding without miscarriage, and anaemia in pregnancy could not be identified; some reviews were rated low quality and none high quality; and included evidence was observational, with possible residual confounding, imprecise results from few events, cross-sectional designs, heterogeneity, incomplete publication bias assessment, and self-reported data.
- The paper also states that presenting absolute numbers on the scale of the problem was not feasible, that causality is unclear, and that the exact magnitude of preventable cardiovascular disease attributable to reproductive risk factors is uncertain.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 155 cited sources checked · 0 supported · 0 flagged
- Findingown data
Gestational hypertension is associated with a 1.5-1.9-fold risk of composite cardiovascular disease.
“Associations for composite cardiovascular disease were: twofold for pre-eclampsia, stillbirth, and preterm birth; 1.5-1.9-fold for gestational hypertension, placental abruption, gestational diabetes, and premature ovarian insufficiency; and less than 1.5-fold for early menarche, polycystic ovary syndrome, ever parity, and early menopause.”
Quote in the paperSubstantial claim - Findingown data
Stillbirth is associated with a twofold risk of composite cardiovascular disease.
“Associations for composite cardiovascular disease were: twofold for pre-eclampsia, stillbirth, and preterm birth; 1.5-1.9-fold for gestational hypertension, placental abruption, gestational diabetes, and premature ovarian insufficiency; and less than 1.5-fold for early menarche, polycystic ovary syndrome, ever parity, and early menopause.”
Quote in the paperSubstantial claim - Findingown data
Preterm birth is associated with a twofold risk of composite cardiovascular disease.
“Associations for composite cardiovascular disease were: twofold for pre-eclampsia, stillbirth, and preterm birth; 1.5-1.9-fold for gestational hypertension, placental abruption, gestational diabetes, and premature ovarian insufficiency; and less than 1.5-fold for early menarche, polycystic ovary syndrome, ever parity, and early menopause.”
Quote in the paperSubstantial claim - Findingown data
Gestational diabetes is associated with a 1.5-1.9-fold risk of composite cardiovascular disease.
“Associations for composite cardiovascular disease were: twofold for pre-eclampsia, stillbirth, and preterm birth; 1.5-1.9-fold for gestational hypertension, placental abruption, gestational diabetes, and premature ovarian insufficiency; and less than 1.5-fold for early menarche, polycystic ovary syndrome, ever parity, and early menopause.”
Quote in the paperSubstantial claim - Findingown data
Premature ovarian insufficiency is associated with a 1.5-1.9-fold risk of composite cardiovascular disease.
“Associations for composite cardiovascular disease were: twofold for pre-eclampsia, stillbirth, and preterm birth; 1.5-1.9-fold for gestational hypertension, placental abruption, gestational diabetes, and premature ovarian insufficiency; and less than 1.5-fold for early menarche, polycystic ovary syndrome, ever parity, and early menopause.”
Quote in the paperSubstantial claim
- Findingown data
Pre-eclampsia is associated with a twofold risk of composite cardiovascular disease.
“Associations for composite cardiovascular disease were: twofold for pre-eclampsia, stillbirth, and preterm birth; 1.5-1.9-fold for gestational hypertension, placental abruption, gestational diabetes, and premature ovarian insufficiency; and less than 1.5-fold for early menarche, polycystic ovary syndrome, ever parity, and early menopause.”
Quote in the paperSubstantial claim - Findingown data
Early menarche is associated with a less than 1.5-fold risk of composite cardiovascular disease.
“Associations for composite cardiovascular disease were: twofold for pre-eclampsia, stillbirth, and preterm birth; 1.5-1.9-fold for gestational hypertension, placental abruption, gestational diabetes, and premature ovarian insufficiency; and less than 1.5-fold for early menarche, polycystic ovary syndrome, ever parity, and early menopause.”
Quote in the paperSubstantial claim - Findingown data
Ever parity is associated with a less than 1.5-fold risk of composite cardiovascular disease.
“Associations for composite cardiovascular disease were: twofold for pre-eclampsia, stillbirth, and preterm birth; 1.5-1.9-fold for gestational hypertension, placental abruption, gestational diabetes, and premature ovarian insufficiency; and less than 1.5-fold for early menarche, polycystic ovary syndrome, ever parity, and early menopause.”
Quote in the paperSubstantial claim - Findingown data
Placental abruption is associated with a 1.5-1.9-fold risk of composite cardiovascular disease.
“Associations for composite cardiovascular disease were: twofold for pre-eclampsia, stillbirth, and preterm birth; 1.5-1.9-fold for gestational hypertension, placental abruption, gestational diabetes, and premature ovarian insufficiency; and less than 1.5-fold for early menarche, polycystic ovary syndrome, ever parity, and early menopause.”
Quote in the paperSubstantial claim - Findingown data
Polycystic ovary syndrome is associated with a less than 1.5-fold risk of composite cardiovascular disease.
“Associations for composite cardiovascular disease were: twofold for pre-eclampsia, stillbirth, and preterm birth; 1.5-1.9-fold for gestational hypertension, placental abruption, gestational diabetes, and premature ovarian insufficiency; and less than 1.5-fold for early menarche, polycystic ovary syndrome, ever parity, and early menopause.”
Quote in the paperSubstantial claim - Findingown data
Early menopause is associated with a less than 1.5-fold risk of composite cardiovascular disease.
“Associations for composite cardiovascular disease were: twofold for pre-eclampsia, stillbirth, and preterm birth; 1.5-1.9-fold for gestational hypertension, placental abruption, gestational diabetes, and premature ovarian insufficiency; and less than 1.5-fold for early menarche, polycystic ovary syndrome, ever parity, and early menopause.”
Quote in the paperSubstantial claim - Findingown data
Polycystic ovary syndrome is associated with a less than 1.5-fold risk of ischaemic heart disease.
“The associations for ischaemic heart disease were twofold or greater for pre-eclampsia, recurrent pre-eclampsia, gestational diabetes, and preterm birth; 1.5-1.9-fold for current use of combined oral contraceptives (oestrogen and progesterone), recurrent miscarriage, premature ovarian insufficiency, and early menopause; and less than 1.5-fold for miscarriage, polycystic ovary syndrome, and menopau”
Quote in the paperSubstantial claim - Findingown data
Menopausal symptoms are associated with a less than 1.5-fold risk of ischaemic heart disease.
“The associations for ischaemic heart disease were twofold or greater for pre-eclampsia, recurrent pre-eclampsia, gestational diabetes, and preterm birth; 1.5-1.9-fold for current use of combined oral contraceptives (oestrogen and progesterone), recurrent miscarriage, premature ovarian insufficiency, and early menopause; and less than 1.5-fold for miscarriage, polycystic ovary syndrome, and menopau”
Quote in the paperSubstantial claim - Findingcitation
Early age at menarche is not associated with mortality from cardiovascular disease.
“No association between early age at menarche and mortality from cardiovascular disease was found.76”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [76] source
Not checked in the free run.
- Findingown data
No association was found between cardiovascular disease outcomes and current use of progesterone only contraceptives.
“No association was found between cardiovascular disease outcomes and current use of progesterone only contraceptives, use of non-oral hormonal contraceptive agents, or fertility treatment.”
Quote in the paperSubstantial claim - Findingown data
Miscarriage is associated with a less than 1.5-fold risk of ischaemic heart disease.
“The associations for ischaemic heart disease were twofold or greater for pre-eclampsia, recurrent pre-eclampsia, gestational diabetes, and preterm birth; 1.5-1.9-fold for current use of combined oral contraceptives (oestrogen and progesterone), recurrent miscarriage, premature ovarian insufficiency, and early menopause; and less than 1.5-fold for miscarriage, polycystic ovary syndrome, and menopau”
Quote in the paperSubstantial claim - Findingown data
Preterm birth is associated with a twofold or greater risk of ischaemic heart disease.
“The associations for ischaemic heart disease were twofold or greater for pre-eclampsia, recurrent pre-eclampsia, gestational diabetes, and preterm birth; 1.5-1.9-fold for current use of combined oral contraceptives (oestrogen and progesterone), recurrent miscarriage, premature ovarian insufficiency, and early menopause; and less than 1.5-fold for miscarriage, polycystic ovary syndrome, and menopau”
Quote in the paperSubstantial claim - Findingown data
Gestational diabetes is associated with a 1.5-1.9-fold risk of stroke.
“For stroke outcomes, the associations were twofold or more for current use of any oral contraceptive (combined oral contraceptives or progesterone only pill), pre-eclampsia, and recurrent pre-eclampsia; 1.5-1.9-fold for current use of combined oral contraceptives, gestational diabetes, and preterm birth; and less than 1.5-fold for polycystic ovary syndrome.”
Quote in the paperSubstantial claim - Findingown data
Recurrent miscarriage is associated with a 1.5-1.9-fold risk of ischaemic heart disease.
“The associations for ischaemic heart disease were twofold or greater for pre-eclampsia, recurrent pre-eclampsia, gestational diabetes, and preterm birth; 1.5-1.9-fold for current use of combined oral contraceptives (oestrogen and progesterone), recurrent miscarriage, premature ovarian insufficiency, and early menopause; and less than 1.5-fold for miscarriage, polycystic ovary syndrome, and menopau”
Quote in the paperSubstantial claim - Findingcitation
Early age at menarche (<12), compared with menarche after age 12, is associated with risk of morbidity from composite cardiovascular disease.
“Early age at menarche (<12), compared with menarche after the age of 12, was associated with a risk of morbidity from composite cardiovascular disease (table 1).78”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [78] source
Not checked in the free run.
- Findingown data
Early age at menarche is associated with risk of mortality from ischaemic heart disease.
“When examined by subtype of cardiovascular disease, an association between early age at menarche and risk of mortality from ischaemic heart disease was seen, but no association with mortality from stroke.”
Quote in the paperSubstantial claim - Findingcitation
Oral contraceptives and non-oral forms of combined hormonal contraceptives are associated with an increased risk of arteriothrombotic events.
“Oral contraceptives and non-oral forms of combined hormonal contraceptives were associated with an increased risk of arteriothrombotic events (table 1).55 67 79”
Quote in the paperSubstantial claim0 of 3 sources checked - Findingown data
Twenty-three reviews reported overlapping associations.
“Twenty three reviews reported overlapping associations.”
Quote in the paperNot a substantial claim - Findingown data
Current use of any oral contraceptive (combined oral contraceptives or progesterone only pill) is associated with a twofold or more risk of stroke.
“For stroke outcomes, the associations were twofold or more for current use of any oral contraceptive (combined oral contraceptives or progesterone only pill), pre-eclampsia, and recurrent pre-eclampsia; 1.5-1.9-fold for current use of combined oral contraceptives, gestational diabetes, and preterm birth; and less than 1.5-fold for polycystic ovary syndrome.”
Quote in the paperSubstantial claim - Findingown data
Current use of combined oral contraceptives is associated with a 1.5-1.9-fold risk of stroke.
“For stroke outcomes, the associations were twofold or more for current use of any oral contraceptive (combined oral contraceptives or progesterone only pill), pre-eclampsia, and recurrent pre-eclampsia; 1.5-1.9-fold for current use of combined oral contraceptives, gestational diabetes, and preterm birth; and less than 1.5-fold for polycystic ovary syndrome.”
Quote in the paperSubstantial claim - Findingown data
Polycystic ovary syndrome is associated with a less than 1.5-fold risk of stroke.
“For stroke outcomes, the associations were twofold or more for current use of any oral contraceptive (combined oral contraceptives or progesterone only pill), pre-eclampsia, and recurrent pre-eclampsia; 1.5-1.9-fold for current use of combined oral contraceptives, gestational diabetes, and preterm birth; and less than 1.5-fold for polycystic ovary syndrome.”
Quote in the paperSubstantial claim - Findingown data
Gestational diabetes is associated with a twofold or greater risk of ischaemic heart disease.
“The associations for ischaemic heart disease were twofold or greater for pre-eclampsia, recurrent pre-eclampsia, gestational diabetes, and preterm birth; 1.5-1.9-fold for current use of combined oral contraceptives (oestrogen and progesterone), recurrent miscarriage, premature ovarian insufficiency, and early menopause; and less than 1.5-fold for miscarriage, polycystic ovary syndrome, and menopau”
Quote in the paperSubstantial claim - Findingown data
All seven low quality reviews did not state that the review methods were established before conducting the review.
“All seven low quality reviews did not meet three of the seven domains considered critical: they had not stated that the review methods were established before conducting the review; they had not used a comprehensive search strategy; and they had not provided a list of excluded studies and the justification for their exclusion.”
Quote in the paperNot a substantial claim - Findingown data
Early age at menarche is not associated with mortality from stroke.
“When examined by subtype of cardiovascular disease, an association between early age at menarche and risk of mortality from ischaemic heart disease was seen, but no association with mortality from stroke.”
Quote in the paperNot a substantial claim - Findingown data
Recurrent pre-eclampsia is associated with a twofold or greater risk of ischaemic heart disease.
“The associations for ischaemic heart disease were twofold or greater for pre-eclampsia, recurrent pre-eclampsia, gestational diabetes, and preterm birth; 1.5-1.9-fold for current use of combined oral contraceptives (oestrogen and progesterone), recurrent miscarriage, premature ovarian insufficiency, and early menopause; and less than 1.5-fold for miscarriage, polycystic ovary syndrome, and menopau”
Quote in the paperSubstantial claim - Findingown data
No association was found between cardiovascular disease outcomes and fertility treatment.
“No association was found between cardiovascular disease outcomes and current use of progesterone only contraceptives, use of non-oral hormonal contraceptive agents, or fertility treatment.”
- Also stated in: § Summary of results by cardiovascular outcome · plain
“No association was found between cardiovascular disease outcomes and fertility treatment, current use of the progesterone only pill, or use of non-oral hormonal contraceptive agents”
- Also stated in: § Main findings · plain
“No association was found between current use of progesterone only contraceptives, use of non-oral combined hormonal contraceptive agents, or fertility treatment and the risk of cardiovascular disease outcomes”
Quote in the paperSubstantial claim - Also stated in: § Summary of results by cardiovascular outcome · plain
- Findingown data
Pre-eclampsia is associated with a fourfold risk of heart failure.
“The association for heart failure was fourfold for pre-eclampsia.”
Quote in the paperSubstantial claim - Findingnone given
A longer length of breastfeeding is associated with a reduced risk of cardiovascular disease.
“A longer length of breastfeeding was associated with a reduced risk of cardiovascular disease.”
Quote in the paperSubstantial claim - Findingown data
Early menopause is associated with a 1.5-1.9-fold risk of ischaemic heart disease.
“The associations for ischaemic heart disease were twofold or greater for pre-eclampsia, recurrent pre-eclampsia, gestational diabetes, and preterm birth; 1.5-1.9-fold for current use of combined oral contraceptives (oestrogen and progesterone), recurrent miscarriage, premature ovarian insufficiency, and early menopause; and less than 1.5-fold for miscarriage, polycystic ovary syndrome, and menopau”
Quote in the paperSubstantial claim - Findingown data
All seven low quality reviews did not provide a list of excluded studies and the justification for their exclusion.
“All seven low quality reviews did not meet three of the seven domains considered critical: they had not stated that the review methods were established before conducting the review; they had not used a comprehensive search strategy; and they had not provided a list of excluded studies and the justification for their exclusion.”
Quote in the paperNot a substantial claim - Findingown data
Pre-eclampsia is associated with a twofold or more risk of stroke.
“For stroke outcomes, the associations were twofold or more for current use of any oral contraceptive (combined oral contraceptives or progesterone only pill), pre-eclampsia, and recurrent pre-eclampsia; 1.5-1.9-fold for current use of combined oral contraceptives, gestational diabetes, and preterm birth; and less than 1.5-fold for polycystic ovary syndrome.”
Quote in the paperSubstantial claim - Findingown data
Pre-eclampsia is associated with a twofold or greater risk of ischaemic heart disease.
“The associations for ischaemic heart disease were twofold or greater for pre-eclampsia, recurrent pre-eclampsia, gestational diabetes, and preterm birth; 1.5-1.9-fold for current use of combined oral contraceptives (oestrogen and progesterone), recurrent miscarriage, premature ovarian insufficiency, and early menopause; and less than 1.5-fold for miscarriage, polycystic ovary syndrome, and menopau”
Quote in the paperSubstantial claim - Findingown data
Preterm birth is associated with a 1.5-1.9-fold risk of stroke.
“For stroke outcomes, the associations were twofold or more for current use of any oral contraceptive (combined oral contraceptives or progesterone only pill), pre-eclampsia, and recurrent pre-eclampsia; 1.5-1.9-fold for current use of combined oral contraceptives, gestational diabetes, and preterm birth; and less than 1.5-fold for polycystic ovary syndrome.”
Quote in the paperSubstantial claim - Findingown data
Recurrent pre-eclampsia is associated with a twofold or more risk of stroke.
“For stroke outcomes, the associations were twofold or more for current use of any oral contraceptive (combined oral contraceptives or progesterone only pill), pre-eclampsia, and recurrent pre-eclampsia; 1.5-1.9-fold for current use of combined oral contraceptives, gestational diabetes, and preterm birth; and less than 1.5-fold for polycystic ovary syndrome.”
Quote in the paperSubstantial claim - Findingown data
Premature ovarian insufficiency is associated with a 1.5-1.9-fold risk of ischaemic heart disease.
“The associations for ischaemic heart disease were twofold or greater for pre-eclampsia, recurrent pre-eclampsia, gestational diabetes, and preterm birth; 1.5-1.9-fold for current use of combined oral contraceptives (oestrogen and progesterone), recurrent miscarriage, premature ovarian insufficiency, and early menopause; and less than 1.5-fold for miscarriage, polycystic ovary syndrome, and menopau”
Quote in the paperSubstantial claim - Findingown data
No association was found between cardiovascular disease outcomes and use of non-oral hormonal contraceptive agents.
“No association was found between cardiovascular disease outcomes and current use of progesterone only contraceptives, use of non-oral hormonal contraceptive agents, or fertility treatment.”
- Also stated in: § Summary of results by cardiovascular outcome · plain
“No association was found between cardiovascular disease outcomes and fertility treatment, current use of the progesterone only pill, or use of non-oral hormonal contraceptive agents”
- Also stated in: § Main findings · plain
“No association was found between current use of progesterone only contraceptives, use of non-oral combined hormonal contraceptive agents, or fertility treatment and the risk of cardiovascular disease outcomes”
Quote in the paperSubstantial claim - Also stated in: § Summary of results by cardiovascular outcome · plain
- Findingown data
Current use of combined oral contraceptives (oestrogen and progesterone) is associated with a 1.5-1.9-fold risk of ischaemic heart disease.
“The associations for ischaemic heart disease were twofold or greater for pre-eclampsia, recurrent pre-eclampsia, gestational diabetes, and preterm birth; 1.5-1.9-fold for current use of combined oral contraceptives (oestrogen and progesterone), recurrent miscarriage, premature ovarian insufficiency, and early menopause; and less than 1.5-fold for miscarriage, polycystic ovary syndrome, and menopau”
Quote in the paperSubstantial claim - Findingcitation
Current users of any oral contraceptive have an increased risk of stroke compared with non-current users.
“Current users of any oral contraceptive (combined oral contraceptives containing a combination of oestrogen and progesterone, or progesterone only pill) had an increased risk of stroke compared with non-current users.67 71”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingown data
All seven low quality reviews did not use a comprehensive search strategy.
“All seven low quality reviews did not meet three of the seven domains considered critical: they had not stated that the review methods were established before conducting the review; they had not used a comprehensive search strategy; and they had not provided a list of excluded studies and the justification for their exclusion.”
Quote in the paperNot a substantial claim - Findingcitation
No association is seen between polycystic ovary syndrome and cardiovascular events in postmenopausal women.
“Results from population based studies suggested that, compared with healthy controls, the risk of cardiovascular events was increased in young women in the reproductive age group with polycystic ovary syndrome (hazard ratio 1.43, 95% confidence interval 1.27 to 1.61); no association was seen in postmenopausal women with polycystic ovary syndrome (supplementary table 3)70 but this review was rated”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [70] Ramezani Tehrani, 2019, Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis, Gynecol Endocrinol
Not checked in the free run.
- Findingcitation
Use of combined oral contraceptives in women with hypertension is associated with a much higher risk of ischaemic stroke (odds ratio 3.1 to 14.5) than in women with normal blood pressure taking non-combined oral contraceptives.
“Use of combined oral contraceptives in women with hypertension women was associated with a much higher risk of myocardial infarction (odds ratio 6 to 68) and ischaemic stroke (odds ratio 3.1 to 14.5) than women with normal blood pressure taking non-combined oral contraceptives.84”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [84] source
Not checked in the free run.
- Findingcitation
Based on one cross sectional study, no association is found between polycystic ovary syndrome and risk of heart failure.
“Based on the results of one cross sectional study,86 no association was found between polycystic ovary syndrome and the risk of heart failure (table 1 and supplementary table 4).87”
Quote in the paperNot a substantial claim0 of 2 sources checked - Findingcitation
Results from population based studies suggest that, compared with healthy controls, the risk of cardiovascular events is increased in young women in the reproductive age group with polycystic ovary syndrome (hazard ratio 1.43, 95% confidence interval 1.27 to 1.61).
“Results from population based studies suggested that, compared with healthy controls, the risk of cardiovascular events was increased in young women in the reproductive age group with polycystic ovary syndrome (hazard ratio 1.43, 95% confidence interval 1.27 to 1.61); no association was seen in postmenopausal women with polycystic ovary syndrome (supplementary table 3)70 but this review was rated”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [70] Ramezani Tehrani, 2019, Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis, Gynecol Endocrinol
Not checked in the free run.
- Findingcitation
The increased risk of composite cardiovascular disease in women with polycystic ovary syndrome is maintained when examining stroke separately.
“This increased risk was maintained when examining ischaemic heart disease66 and stroke85 separately (supplementary table 3).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [85] source
Not checked in the free run.
- Findingcitation
Women with polycystic ovary syndrome have a 1.3-fold greater risk of developing composite cardiovascular disease than women who do not have polycystic ovary syndrome.
“Women with polycystic ovary syndrome had a 1.3-fold greater risk of developing composite cardiovascular disease than women who did not have polycystic ovary syndrome (table 1).66”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [66] source
Not checked in the free run.
- Findingcitation
Women receiving fertility treatment have no greater risk of developing composite cardiovascular disease than infertile women not on fertility treatment.
“Women receiving fertility treatment (ovulation induction, in vitro fertilisation, and intrauterine insemination with drug treatment) had no greater risk of developing composite cardiovascular disease or stroke than infertile women not on fertility treatment.88”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [88] source
Not checked in the free run.
- Findingcitation
Women receiving fertility treatment have no greater risk of stroke than infertile women not on fertility treatment.
“Women receiving fertility treatment (ovulation induction, in vitro fertilisation, and intrauterine insemination with drug treatment) had no greater risk of developing composite cardiovascular disease or stroke than infertile women not on fertility treatment.88”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [88] source
Not checked in the free run.
- Findingcitation
In women with dyslipidaemia, users of combined hormonal contraceptive agents are at increased risk of cerebrovascular accident compared with non-users.
“Similarly, in women with dyslipidaemia,80 results derived from one primary study reported in the systematic review showed that users of combined hormonal contraceptive agents were at an increased risk of myocardial infarction82 and cerebrovascular accident compared with non-users (table 1).83”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingcitation
In women with dyslipidaemia, users of combined hormonal contraceptive agents are at increased risk of myocardial infarction compared with non-users.
“Similarly, in women with dyslipidaemia,80 results derived from one primary study reported in the systematic review showed that users of combined hormonal contraceptive agents were at an increased risk of myocardial infarction82 and cerebrovascular accident compared with non-users (table 1).83”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingcitation
The risk of stroke in women diagnosed with migraine is 2-16-fold greater for those taking combined hormonal contraceptive agents than for those not taking combined hormonal contraceptives.
“The risk of stroke in women diagnosed with migraine was 2-16-fold greater for those taking combined hormonal contraceptive agents than those not taking combined hormonal contraceptives (table 1).74”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [74]
Not checked in the free run.
- Findingcitation
Current use of the progesterone only pill is not associated with risk of myocardial infarction or stroke.
“In contrast, no association was seen between current use of the progesterone only pill and risk of myocardial infarction or stroke.72”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [72] source
Not checked in the free run.
- Findingcitation
Comparing users of non-oral combined hormonal contraceptive agents with users of combined oral contraceptives, no association with stroke is seen.
“Comparing users of non-oral combined hormonal contraceptive agents with users of combined oral contraceptives,79 no association with the development of myocardial infarction (the results were not meta-analysed, but odds ratios from individual primary studies ranged from 0.2 to 1.6) or stroke (odds ratio 0.8 to 1.2) was seen but the review was rated as low quality (table 1 and supplementary table 4”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [79] source
Not checked in the free run.
- Findingcitation
Use of combined oral contraceptives in women with hypertension is associated with a much higher risk of myocardial infarction (odds ratio 6 to 68) than in women with normal blood pressure taking non-combined oral contraceptives.
“Use of combined oral contraceptives in women with hypertension women was associated with a much higher risk of myocardial infarction (odds ratio 6 to 68) and ischaemic stroke (odds ratio 3.1 to 14.5) than women with normal blood pressure taking non-combined oral contraceptives.84”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [84] source
Not checked in the free run.
- Findingcitation
Comparing users of non-oral combined hormonal contraceptive agents with users of combined oral contraceptives, no association with development of myocardial infarction is seen.
“Comparing users of non-oral combined hormonal contraceptive agents with users of combined oral contraceptives,79 no association with the development of myocardial infarction (the results were not meta-analysed, but odds ratios from individual primary studies ranged from 0.2 to 1.6) or stroke (odds ratio 0.8 to 1.2) was seen but the review was rated as low quality (table 1 and supplementary table 4”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [79] source
Not checked in the free run.
- Findingcitation
Use of hormonal contraceptive agents is associated with an additional risk of cardiovascular disease in women who have coexisting medical conditions.
“Use of hormonal contraceptive agents was associated with an additional risk of cardiovascular disease in women who had coexisting medical conditions.74 80 81”
Quote in the paperSubstantial claim0 of 3 sources checked - Findingcitation
Current users of combined oral contraceptives have a greater risk of developing myocardial infarction and stroke than non-current users of combined oral contraceptives.
“Current users of combined oral contraceptives had a greater risk of developing myocardial infarction and stroke than non-current users of combined oral contraceptives.55”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55] source
Not checked in the free run.
- Findingcitation
The increase in stroke risk for current users of any oral contraceptive is greater for ischaemic stroke than for haemorrhagic stroke.
“The increase in risk was greater for ischaemic stroke67 than haemorrhagic stroke.71”
Quote in the paperNot a substantial claim0 of 2 sources checked - Findingcitation
Use of combined hormonal contraceptives in women with a high body mass index (>27.3 kg/m2) is not a multiplicative or additive risk factor for development of myocardial infarction or stroke.
“But use of combined hormonal contraceptives in women with a high body mass index (>27.3 kg/m2) was not found to be a multiplicative or additive risk factor for the development of myocardial infarction or stroke (table 1).81”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [81] source
Not checked in the free run.
- Findingcitation
The increased risk of composite cardiovascular disease in women with polycystic ovary syndrome is maintained when examining ischaemic heart disease separately.
“This increased risk was maintained when examining ischaemic heart disease66 and stroke85 separately (supplementary table 3).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [66] source
Not checked in the free run.
- Findingcitation
Early menopause is not associated with an increased risk of stroke.
“Specifically, an increased risk of developing ischaemic heart disease (fatal and non-fatal outcomes) but not stroke was seen.57”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] source
Not checked in the free run.
- Findingcitation
In a cohort of Chinese women, ever breastfeeding is not associated with mortality from stroke.
“In a cohort of Chinese women,94 mortality from ischaemic heart disease but not stroke was lower in women who ever breastfed than in those who never breastfed.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [94] source
Not checked in the free run.
- Findingcitation
Early menopause is associated with an increased risk of developing ischaemic heart disease (fatal and non-fatal outcomes).
“Specifically, an increased risk of developing ischaemic heart disease (fatal and non-fatal outcomes) but not stroke was seen.57”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [57] source
Not checked in the free run.
- Findingcitation
For non-fatal events, the risk of composite cardiovascular disease increases by 4% for each live birth.
“For non-fatal events,90 however, the risk of composite cardiovascular disease was increased in ever parous women, with the risk increasing by 4% for each live birth.90”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [90] source
Not checked in the free run.
- Findingcitation
Compared with women who did not breastfeed, two US cohort studies found that morbidity from composite cardiovascular disease is lower in women with a lifetime length of lactation of more than 12 months.
“Compared with women who did not breastfeed, two US cohort studies found that morbidity from myocardial infarction92 and composite cardiovascular disease93 was lower in women with a lifetime length of lactation of more than 12 months.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [93] source
Not checked in the free run.
- Findingcitation
Early (aged <45) natural menopause is not associated with risk of mortality from composite cardiovascular disease.
“Early (aged <45) natural menopause was not associated with a risk of mortality from composite cardiovascular disease or stroke, but was associated with a risk of mortality as a result of ischaemic heart disease.59”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [59] source
Not checked in the free run.
- Findingcitation
The findings on early menopause are reflected in an association with mortality risk from ischaemic heart disease.
“These findings were also reflected in the association with mortality risk from ischaemic heart disease, but not mortality from stroke or composite cardiovascular disease.59”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] source
Not checked in the free run.
- Findingcitation
The risk of ischaemic heart disease is increased in women with menopausal symptoms.
“No association was seen between menopausal symptoms and risk of composite cardiovascular disease or stroke compared with women without menopausal symptoms97 but the risk was increased for ischaemic heart disease.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [97] source
Not checked in the free run.
- Findingcitation
No association is seen between menopausal symptoms and risk of composite cardiovascular disease compared with women without menopausal symptoms.
“No association was seen between menopausal symptoms and risk of composite cardiovascular disease or stroke compared with women without menopausal symptoms97 but the risk was increased for ischaemic heart disease.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [97] source
Not checked in the free run.
- Findingcitation
The findings on early menopause are not reflected in an association with mortality from composite cardiovascular disease.
“These findings were also reflected in the association with mortality risk from ischaemic heart disease, but not mortality from stroke or composite cardiovascular disease.59”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [59] source
Not checked in the free run.
- Findingcitation
Early (aged <45) natural menopause is not associated with risk of mortality from stroke.
“Early (aged <45) natural menopause was not associated with a risk of mortality from composite cardiovascular disease or stroke, but was associated with a risk of mortality as a result of ischaemic heart disease.59”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] source
Not checked in the free run.
- Findingcitation
In a cohort of Norwegian women, women aged 65 or younger who never breastfed are at higher risk of mortality from stroke than women who ever breastfed.
“In a cohort of Norwegian women,95 women aged 65 or younger and who never breastfed were at a higher risk of mortality from stroke than women who ever breastfed.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [95] source
Not checked in the free run.
- Findingcitation
The association between early menopause and composite cardiovascular disease is related to development of ischaemic heart disease.
“This association was related to the development of ischaemic heart disease96; no association was found with stroke.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [96] source
Not checked in the free run.
- Findingcitation
No association is found between early menopause and stroke.
“This association was related to the development of ischaemic heart disease96; no association was found with stroke.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [96] source
Not checked in the free run.
- Findingcitation
A history of miscarriage is not associated with an increased risk of composite cardiovascular disease.
“A history of miscarriage was not associated with an increased risk of composite cardiovascular disease (table 1).60”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] source
Not checked in the free run.
- Findingown data
In a dose-response analysis, the association between ever parity and mortality from composite cardiovascular disease follows a J shaped curve with the risk lowest at a parity of four.
“In a dose-response analysis, the association between ever parity and mortality from composite cardiovascular disease followed a J shaped curve with the risk lowest at a parity of four.”
Quote in the paperNot a substantial claim - Findingcitation
Compared with women who did not breastfeed, two US cohort studies found that morbidity from myocardial infarction is lower in women with a lifetime length of lactation of more than 12 months.
“Compared with women who did not breastfeed, two US cohort studies found that morbidity from myocardial infarction92 and composite cardiovascular disease93 was lower in women with a lifetime length of lactation of more than 12 months.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [92] source
Not checked in the free run.
- Findingcitation
For non-fatal events, the risk of composite cardiovascular disease is increased in ever parous women.
“For non-fatal events,90 however, the risk of composite cardiovascular disease was increased in ever parous women, with the risk increasing by 4% for each live birth.90”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [90] source
Not checked in the free run.
- Findingcitation
Evidence synthesised from four studies suggests that breastfeeding is associated with an overall reduction in maternal cardiovascular disease.
“Evidence synthesised from four studies suggested that breastfeeding was associated with an overall reduction in maternal cardiovascular disease.91”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [91] source
Not checked in the free run.
- Findingcitation
Mortality from composite cardiovascular disease is lower in ever parous women than in nulliparous women.
“Mortality from composite cardiovascular disease was lower in ever parous women than nulliparous women (table 1).89”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] source
Not checked in the free run.
- Findingcitation
The findings on early menopause are not reflected in an association with mortality from stroke.
“These findings were also reflected in the association with mortality risk from ischaemic heart disease, but not mortality from stroke or composite cardiovascular disease.59”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] source
Not checked in the free run.
- Findingcitation
In a cohort of Chinese women, mortality from ischaemic heart disease is lower in women who ever breastfed than in those who never breastfed.
“In a cohort of Chinese women,94 mortality from ischaemic heart disease but not stroke was lower in women who ever breastfed than in those who never breastfed.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [94] source
Not checked in the free run.
- Findingcitation
Women who experienced menopause earlier than age 40 (premature ovarian insufficiency) have a 1.6-fold risk of developing composite cardiovascular disease compared with women without premature ovarian insufficiency.
“Overall, women who experienced menopause earlier than age 40 (premature ovarian insufficiency) had a 1.6-fold risk of developing composite cardiovascular disease compared with women without premature ovarian insufficiency.96”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [96] source
Not checked in the free run.
- Findingcitation
Early (aged <45) natural menopause is associated with risk of mortality as a result of ischaemic heart disease.
“Early (aged <45) natural menopause was not associated with a risk of mortality from composite cardiovascular disease or stroke, but was associated with a risk of mortality as a result of ischaemic heart disease.59”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] source
Not checked in the free run.
- Findingcitation
Women who had experienced early (aged <45) menopause (natural and unnatural) have a 20% higher risk of mortality after cardiovascular disease than women who had experienced menopause at age 45 or older.
“Women who had experienced early (aged <45) menopause (natural and unnatural) had a 20% higher risk of mortality after cardiovascular disease than women who had experienced menopause at age 45 or older.57”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [57] source
Not checked in the free run.
- Findingcitation
No association is seen between menopausal symptoms and risk of stroke compared with women without menopausal symptoms.
“No association was seen between menopausal symptoms and risk of composite cardiovascular disease or stroke compared with women without menopausal symptoms97 but the risk was increased for ischaemic heart disease.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [97] source
Not checked in the free run.
- Findingcitation
In comparison with an episode of pre-eclampsia followed by a healthy pregnancy, a history of recurrent pre-eclampsia is associated with an increased risk of heart failure.
“In comparison with an episode of pre-eclampsia followed by a healthy pregnancy, a history of recurrent pre-eclampsia was associated with an increased risk of composite cardiovascular disease, coronary heart disease, heart failure, and cerebrovascular accident.99”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [99] source
Not checked in the free run.
- Findingcitation
Gestational hypertension is linked to a greater risk of morbidity from composite cardiovascular disease.
“Gestational hypertension was linked to a greater risk of morbidity from composite cardiovascular disease but not stroke.60”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] source
Not checked in the free run.
- Findingcitation
Preterm delivery is associated with an increased risk of fatal and non-fatal composite cardiovascular disease.
“Preterm delivery was associated with an increased risk of fatal and non-fatal composite cardiovascular disease.102 60”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingcitation
A history of pre-eclampsia is associated with higher odds of non-fatal stroke.
“For subtypes of cardiovascular disease, a history of pre-eclampsia was associated with a higher odds of experiencing heart failure,61 fatal ischaemic heart disease,61 and non-fatal stroke,60 but not fatal stroke.61”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] source
Not checked in the free run.
- Findingcitation
In comparison with an episode of pre-eclampsia followed by a healthy pregnancy, a history of recurrent pre-eclampsia is associated with an increased risk of cerebrovascular accident.
“In comparison with an episode of pre-eclampsia followed by a healthy pregnancy, a history of recurrent pre-eclampsia was associated with an increased risk of composite cardiovascular disease, coronary heart disease, heart failure, and cerebrovascular accident.99”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [99] source
Not checked in the free run.
- Findingcitation
In comparison with an episode of pre-eclampsia followed by a healthy pregnancy, a history of recurrent pre-eclampsia is associated with an increased risk of coronary heart disease.
“In comparison with an episode of pre-eclampsia followed by a healthy pregnancy, a history of recurrent pre-eclampsia was associated with an increased risk of composite cardiovascular disease, coronary heart disease, heart failure, and cerebrovascular accident.99”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [99] source
Not checked in the free run.
- Findingcitation
The risk of cardiovascular disease in women with a history of gestational diabetes persists when analysed by subtype coronary artery disease.
“The risk persisted when analysed by subtype of cardiovascular disease (coronary artery disease and stroke).63”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [63] source
Not checked in the free run.
- Findingcitation
Evidence of an association between gestational diabetes and heart failure is inconclusive.
“Evidence of an association between gestational diabetes and heart failure87 was inconclusive however (supplementary table 4).100 101”
Quote in the paperNot a substantial claim0 of 3 sources checked - Findingcitation
Overall, women with a history of pre-eclampsia (both moderate and severe pre-eclampsia) are at increased risk of mortality and morbidity from composite cardiovascular disease compared with those without a history of pre-eclampsia.
“Overall, women with a history of pre-eclampsia (both moderate and severe pre-eclampsia) were at an increased risk of mortality and morbidity from composite cardiovascular disease compared with those without a history of pre-eclampsia (table 1).60”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] source
Not checked in the free run.
- Findingcitation
In a review exploring individual cardiovascular diseases, miscarriage is not linked to a higher risk of stroke.
“In a review exploring individual cardiovascular diseases, miscarriage was linked to a higher risk of ischaemic heart disease but not of stroke.98”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [98] source
Not checked in the free run.
- Findingcitation
A history of pre-eclampsia is associated with higher odds of experiencing heart failure.
“For subtypes of cardiovascular disease, a history of pre-eclampsia was associated with a higher odds of experiencing heart failure,61 fatal ischaemic heart disease,61 and non-fatal stroke,60 but not fatal stroke.61”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [61] source
Not checked in the free run.
- Findingcitation
A history of placental abruption is associated with higher odds of composite cardiovascular disease.
“A history of placental abruption was associated with a higher odds of composite cardiovascular disease.60”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] source
Not checked in the free run.
- Findingcitation
The risk of non-fatal ischaemic heart disease in women with pre-eclampsia was 1.7-2-fold in the two reviews.
“The risk of non-fatal ischaemic heart disease in women with pre-eclampsia was 1.7-2-fold in the two reviews.60 61”
Quote in the paperNot a substantial claim0 of 2 sources checked - Findingcitation
Gestational hypertension is not linked to stroke.
“Gestational hypertension was linked to a greater risk of morbidity from composite cardiovascular disease but not stroke.60”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] source
Not checked in the free run.
- Findingcitation
Women with a history of gestational diabetes have a greater risk of composite cardiovascular disease than those without gestational diabetes.
“Women with a history of gestational diabetes had a greater risk of composite cardiovascular disease than those without gestational diabetes (table 1).62”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [62] source
Not checked in the free run.
- Findingcitation
In comparison with an episode of pre-eclampsia followed by a healthy pregnancy, a history of recurrent pre-eclampsia is associated with an increased risk of composite cardiovascular disease.
“In comparison with an episode of pre-eclampsia followed by a healthy pregnancy, a history of recurrent pre-eclampsia was associated with an increased risk of composite cardiovascular disease, coronary heart disease, heart failure, and cerebrovascular accident.99”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [99] source
Not checked in the free run.
- Findingcitation
A history of pre-eclampsia is not associated with fatal stroke.
“For subtypes of cardiovascular disease, a history of pre-eclampsia was associated with a higher odds of experiencing heart failure,61 fatal ischaemic heart disease,61 and non-fatal stroke,60 but not fatal stroke.61”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61] source
Not checked in the free run.
- Findingcitation
In a review exploring individual cardiovascular diseases, miscarriage is linked to a higher risk of ischaemic heart disease.
“In a review exploring individual cardiovascular diseases, miscarriage was linked to a higher risk of ischaemic heart disease but not of stroke.98”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [98] source
Not checked in the free run.
- Findingcitation
The risk of composite cardiovascular disease in women with a history of gestational diabetes is highest in the first decade after pregnancy.
“The risk was highest in the first decade after pregnancy.62”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [62] source
Not checked in the free run.
- Findingcitation
The risk of cardiovascular disease in women with a history of gestational diabetes persists when analysed by subtype stroke.
“The risk persisted when analysed by subtype of cardiovascular disease (coronary artery disease and stroke).63”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [63] source
Not checked in the free run.
- Findingcitation
A history of pre-eclampsia is associated with higher odds of fatal ischaemic heart disease.
“For subtypes of cardiovascular disease, a history of pre-eclampsia was associated with a higher odds of experiencing heart failure,61 fatal ischaemic heart disease,61 and non-fatal stroke,60 but not fatal stroke.61”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [61] source
Not checked in the free run.
- Findingcitation
Women with a history of stillbirth have a greater risk of morbidity and mortality from composite cardiovascular disease than women with no history of stillbirth.
“Women with a history of stillbirth had a greater risk of morbidity and mortality from composite cardiovascular disease than women with no history of stillbirth.60”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] source
Not checked in the free run.
- Findingcitation
For subtypes of cardiovascular disease, the risk is increased in non-fatal ischaemic heart disease in women with preterm delivery.
“For subtypes of cardiovascular disease, the risk was increased in non-fatal ischaemic heart disease, fatal ischaemic heart disease, and non-fatal stroke.64”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [64] source
Not checked in the free run.
- Findingcitation
Two cohort studies showed that a longer length of breastfeeding is associated with reduced morbidity from coronary heart disease compared with never breastfed.
“Two cohort studies showed that a longer length of breastfeeding was associated with reduced morbidity from coronary heart disease compared with never breastfed.115 116”
Quote in the paperNot a substantial claim0 of 2 sources checked - Findingcitation
The risk of composite cardiovascular disease tends to be higher in women with babies of low birth weight than in women who delivered babies with an average birth weight.
“The risk of composite cardiovascular disease tended to be higher in women with babies of low birth weight than in women who delivered babies with an average birth weight (table 1).60”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] source
Not checked in the free run.
- Findingcitation
For subtypes of cardiovascular disease, the risk is increased in fatal ischaemic heart disease in women with preterm delivery.
“For subtypes of cardiovascular disease, the risk was increased in non-fatal ischaemic heart disease, fatal ischaemic heart disease, and non-fatal stroke.64”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [64] source
Not checked in the free run.
- Findingcitation
Mortality from composite cardiovascular disease tends to be lower in women who breastfed for longer than in those who never breastfed, as assessed by two cohort studies.
“Mortality from composite cardiovascular disease tended to be lower in women who breastfed for longer than in those who never breastfed, as assessed by two cohort studies.111 116”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingcitation
A large Danish cohort study found that women who had a miscarriage were at higher risk of stroke (incidence rate ratio 1.16, 95% confidence interval 1.07 to 1.25).
“A large (1 031 279 participants) Danish cohort study103 noted that women who had a miscarriage were at a higher risk of stroke (incidence rate ratio 1.16, 95% confidence interval 1.07 to 1.25).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [103] source
Not checked in the free run.
- Findingown data
Incorporating the results of the Danish cohort study into the meta-analysis on risk of stroke with the existing systematic review did not alter the significance of the association between miscarriage and stroke.
“Incorporating the results in the meta-analysis on the risk of stroke with those of the existing systematic review98 did not alter the significance of the association between miscarriage and stroke.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [98] source
Not checked in the free run.
- Findingcitation
Two recent studies found no association between gestational diabetes and risk of stroke (hazard ratio 1.10, 95% confidence interval 0.75 to 1.61; incidence rate ratio 0.95, 95% confidence interval 0.51 to 1.77).
“Two recent studies107 108 found no association between gestational diabetes and the risk of stroke (hazard ratio 1.10, 95% confidence interval 0.75 to 1.61; incidence rate ratio 0.95, 95% confidence interval 0.51 to 1.77, respectively).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Findingcitation
A longer length of breastfeeding is associated with a reduced risk of non-fatal composite cardiovascular disease compared with never breastfed in all three cohort studies.
“A longer length of breastfeeding was associated with a reduced risk of non-fatal composite cardiovascular disease compared with never breastfed in all three cohort studies.111 114 116”
Quote in the paperSubstantial claim0 of 3 sources checked - Findingcitation
The risk of composite cardiovascular disease is greater in women with multiple preterm births than in women with one preterm birth.
“The risk of composite cardiovascular disease was greater in women with multiple preterm births than in women with one preterm birth (table 1 and supplementary table 4).65”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [65] source
Not checked in the free run.
- Findingcitation
Longer length of breastfeeding versus never breastfed is associated with reduced morbidity from stroke in two cohort studies.
“Longer length of breastfeeding versus never breastfed was associated with reduced morbidity from stroke in two cohort studies.113 116”
Quote in the paperNot a substantial claim0 of 2 sources checked - Findingcitation
For subtypes of cardiovascular disease, the risk is increased in non-fatal stroke in women with preterm delivery.
“For subtypes of cardiovascular disease, the risk was increased in non-fatal ischaemic heart disease, fatal ischaemic heart disease, and non-fatal stroke.64”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [64] source
Not checked in the free run.
- Findingcitation
Small for gestational age is linked to an increased risk of morbidity and mortality from maternal cardiovascular disease (odds ratio 1.09 to 3.50).
“Small for gestational age was linked to an increased risk of morbidity and mortality from maternal cardiovascular disease (odds ratio 1.09 to 3.50) (supplementary table 4).60”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] source
Not checked in the free run.
- Findingcitation
When the results were incorporated into the meta-analysis on gestational diabetes and risk of stroke, the association between gestational diabetes and risk of stroke was maintained (risk ratio 1.21, 95% confidence interval 1.05 to 1.40).
“When the results were incorporated into the meta-analysis on gestational diabetes and risk of stroke,63 the association between gestational diabetes and risk of stroke was maintained (risk ratio 1.21, 95% confidence interval 1.05 to 1.40).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [63] source
Not checked in the free run.
- Findingcitation
In the case-control study, a U shaped association between length of breastfeeding and morbidity from coronary heart disease was seen, with the lowest risk in women who breastfed for 16-26 months over a total lifetime.
“In the case-control study, a U shaped association between length of breastfeeding and morbidity from coronary heart disease was seen, with the lowest risk in women who breastfed for 16-26 months over a total lifetime.112”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [112] source
Not checked in the free run.
- Findingown data
Polycystic ovary syndrome was associated with a less than 1.5-fold increase in risk of stroke.
“polycystic ovary syndrome was associated with a less than 1.5-fold increase in risk”
Quote in the paperNot a substantial claim - Findingown data
Premature ovarian insufficiency, placental abruption, gestational hypertension, and gestational diabetes mellitus were associated with a 1.5-1.9-fold increase in the risk of composite cardiovascular disease.
“premature ovarian insufficiency, placental abruption, gestational hypertension, and gestational diabetes mellitus were associated with a 1.5-1.9-fold increase in the risk”
Quote in the paperSubstantial claim - Findingown data
Preterm birth, pre-eclampsia, and stillbirth were associated with a twofold increase in the risk of composite cardiovascular disease.
“Preterm birth, pre-eclampsia, and stillbirth were associated with a twofold increase in the risk of composite cardiovascular disease”
Quote in the paperSubstantial claim - Findingcitation
Polycystic ovary syndrome, menopausal symptoms, and miscarriage were associated with a less than 1.5-fold increased risk of ischaemic heart disease.
“polycystic ovary syndrome, menopausal symptoms, and miscarriage were associated with a less than 1.5-fold increased risk”
Quote in the paperSubstantial claim - Findingnone given
The evidence was inconclusive on the association between use of combined hormonal contraceptive agents in women with a high body mass index (>27.3) and the risk of cardiovascular disease outcomes.
“The evidence was inconclusive on the association between use of combined hormonal contraceptive agents in women with a high body mass index (>27.3) and the risk of cardiovascular disease outcomes”
Quote in the paperSubstantial claim - Findingnone given
No association was found between cardiovascular disease outcomes and current use of the progesterone only pill.
“No association was found between cardiovascular disease outcomes and fertility treatment, current use of the progesterone only pill, or use of non-oral hormonal contraceptive agents”
- Also stated in: § Main findings · plain
“No association was found between current use of progesterone only contraceptives, use of non-oral combined hormonal contraceptive agents, or fertility treatment and the risk of cardiovascular disease outcomes”
Quote in the paperSubstantial claim - Also stated in: § Main findings · plain
- Findingcitation
Pre-eclampsia was associated with a fourfold increase in the risk of heart failure.
“Pre-eclampsia was associated with a fourfold increase in the risk of heart failure”
Quote in the paperSubstantial claim - Findingown data
Polycystic ovary syndrome, early menopause, early menarche, and ever parity were associated with a less than 1.5-fold increase in the risk of composite cardiovascular disease.
“polycystic ovary syndrome, early menopause, early menarche, and ever parity were associated with a less than 1.5-fold increase in risk”
Quote in the paperSubstantial claim - Findingcitation
Breastfeeding for longer was associated with a reduced risk of cardiovascular disease.
“Breastfeeding for longer was associated with a reduced risk of cardiovascular disease”
- Also stated in: § Main findings · hedged
“The review on length of lactation and the recently published studies suggest that breastfeeding for longer reduces the risk of cardiovascular disease”
Quote in the paperSubstantial claim - Also stated in: § Main findings · hedged
- Findingown data
No evidence of an increased risk of heart failure in women with polycystic ovary syndrome was found.
“no evidence of an increased risk of heart failure in women with polycystic ovary syndrome was found”
Quote in the paperNot a substantial claim - Study design and conductown data
Reviews assessing the association between use of combined oral contraceptives in women with a high body mass index and risk of myocardial infarction or stroke were rated as low quality.
“Reviews assessing the association between the use of combined oral contraceptives in women with a high body mass index and the risk of myocardial infarction or stroke were rated as low quality (appendix 7).”
Quote in the paperNot a substantial claim - Study design and conductcitation
The review comparing non-oral combined hormonal contraceptives with combined oral contraceptives was rated as low quality.
“Comparing users of non-oral combined hormonal contraceptive agents with users of combined oral contraceptives,79 no association with the development of myocardial infarction (the results were not meta-analysed, but odds ratios from individual primary studies ranged from 0.2 to 1.6) or stroke (odds ratio 0.8 to 1.2) was seen but the review was rated as low quality (table 1 and supplementary table 4”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [79] source
Not checked in the free run.
- Premiseown data
In a cohort of 289,573 Chinese women aged 30-79, lifetime lactation duration 24-36 months compared with never breastfed in parous women was associated with a hazard ratio of 0.93 (95% CI 0.85 to 1.02) for fatal composite cardiovascular disease.
“Fatal composite cardiovascular disease | 24-36 months, HR 0.93 (0.85 to 1.02)”
Quote in the paperNot a substantial claim - Premiseown data
In a cohort of 289,573 Chinese women aged 30-79, lifetime lactation duration 24-36 months compared with never breastfed in parous women was associated with a hazard ratio of 0.86 (95% CI 0.83 to 0.89) for non-fatal coronary heart disease.
“Non-fatal coronary heart disease | 24-36 months, HR 0.86 (0.83 to 0.89)”
Quote in the paperSubstantial claim - Premiseown data
In a cohort of 289,573 Chinese women aged 30-79, lifetime lactation duration >48 months compared with never breastfed in parous women was associated with a hazard ratio of 0.85 (95% CI 0.82 to 0.89) for non-fatal coronary heart disease.
“Non-fatal coronary heart disease | >48 months, HR 0.85 (0.82 to 0.89)”
Quote in the paperSubstantial claim - Premiseown data
In a cohort of 289,573 Chinese women aged 30-79, lifetime lactation duration >48 months compared with never breastfed in parous women was associated with a hazard ratio of 0.91 (95% CI 0.88 to 0.93) for non-fatal composite cardiovascular disease.
“Non-fatal compositecardiovascular disease | >48 months, HR 0.91 (0.88 to 0.93)”
Quote in the paperSubstantial claim - Premiseown data
In a cohort of 289,573 Chinese women aged 30-79, lifetime lactation duration 0-12 months compared with never breastfed in parous women was associated with a hazard ratio of 0.93 (95% CI 0.89 to 0.97) for non-fatal stroke.
“Non-fatal stroke | 0-12 months, HR 0.93 (0.89 to 0.97)”
Quote in the paperNot a substantial claim - Premiseown data
In a cohort of 289,573 Chinese women aged 30-79, lifetime lactation duration 12-24 months compared with never breastfed in parous women was associated with a hazard ratio of 0.98 (95% CI 0.87 to 1.09) for fatal composite cardiovascular disease.
“Fatal composite cardiovascular disease | 12-24 months, HR 0.98 (0.87 to1.09)”
Quote in the paperNot a substantial claim - Premiseown data
In a cohort of 289,573 Chinese women aged 30-79, never breastfeeding compared with breastfeeding was associated with a hazard ratio of 1.00 (95% CI 0.92 to 1.09) for non-fatal coronary heart disease.
“Non-fatal coronary heart disease | Never breastfed, HR 1.00 (0.92 to 1.09)”
Quote in the paperNot a substantial claim - Premiseown data
In a cohort of 289,573 Chinese women aged 30-79, lifetime lactation duration 36-48 months compared with never breastfed in parous women was associated with a hazard ratio of 0.86 (95% CI 0.82 to 0.89) for non-fatal stroke.
“Non-fatal stroke | 36-48 months, HR 0.86 (0.82 to 0.89)”
Quote in the paperSubstantial claim - Premiseown data
In a cohort of 289,573 Chinese women aged 30-79, lifetime lactation duration >48 months compared with never breastfed in parous women was associated with a hazard ratio of 0.85 (95% CI 0.82 to 0.89) for non-fatal stroke.
“Non-fatal stroke | >48 months, HR 0.85 (0.82 to 0.89)”
Quote in the paperSubstantial claim - Premiseown data
In a cohort of 289,573 Chinese women aged 30-79, never breastfeeding compared with breastfeeding was associated with a hazard ratio of 1.00 (95% CI 0.93 to 1.08) for non-fatal stroke.
“Non-fatal stroke | Never breastfed, HR 1.00 (0.93 to 1.08)”
Quote in the paperNot a substantial claim - Premisecitation
In a cohort of 8044 parous women, lifetime duration of breastfeeding 0-3 months compared with never breastfed was associated with a hazard ratio of 0.73 (95% CI 0.60 to 0.89) for non-fatal coronary heart disease.
“Non-fatal coronary heart disease | 0-3 months HR 0.73 (0.60 to 0.89)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Peters 2016
Not checked in the free run.
- Interpretationreasoning
Newly published observational studies support an inverse association between length of lactation and morbidity or mortality from cardiovascular disease.
“In summary, newly published observational studies support an inverse association between length of lactation and morbidity or mortality from cardiovascular disease.”
Quote in the paperSubstantial claim - Premiseown data
In a cohort of 289,573 Chinese women aged 30-79, lifetime lactation duration 36-48 months compared with never breastfed in parous women was associated with a hazard ratio of 0.86 (95% CI 0.82 to 0.90) for non-fatal coronary heart disease.
“Non-fatal coronary heart disease | 36-48 months, HR 0.86 (0.82 to 0.90)”
Quote in the paperSubstantial claim - Premiseown data
In a cohort of 289,573 Chinese women aged 30-79, lifetime lactation duration 0-12 months compared with never breastfed in parous women was associated with a hazard ratio of 0.93 (95% CI 0.89 to 0.99) for non-fatal coronary heart disease.
“Non-fatal coronary heart disease | 0-12 months, HR 0.93 (0.89 to 0.99)”
Quote in the paperSubstantial claim - Premiseown data
In a cohort of 289,573 Chinese women aged 30-79, lifetime lactation duration 12-24 months compared with never breastfed in parous women was associated with a hazard ratio of 0.92 (95% CI 0.89 to 0.96) for non-fatal coronary heart disease.
“Non-fatal coronary heart disease | 12-24 months, HR 0.92 (0.89 to 0.96)”
Quote in the paperSubstantial claim - Premiseown data
In a cohort of 289,573 Chinese women aged 30-79, lifetime lactation duration 12-24 months compared with never breastfed in parous women was associated with a hazard ratio of 0.93 (95% CI 0.90 to 0.96) for non-fatal stroke.
“Non-fatal stroke | 12-24 months, HR 0.93 (0.90 to 0.96)”
Quote in the paperNot a substantial claim - Premiseown data
In a cohort of 289,573 Chinese women aged 30-79, lifetime lactation duration 0-12 months compared with never breastfed in parous women was associated with a hazard ratio of 0.88 (95% CI 0.74 to 1.04) for fatal composite cardiovascular disease.
“Fatal composite cardiovascular disease | 0-12 months, HR 0.88 (0.74 to 1.04)”
Quote in the paperNot a substantial claim - Premiseown data
In a cohort of 289,573 Chinese women aged 30-79, lifetime lactation duration 36-48 months compared with never breastfed in parous women was associated with a hazard ratio of 0.81 (95% CI 0.74 to 0.89) for fatal composite cardiovascular disease.
“Fatal composite cardiovascular disease | 36-48 months, HR 0.81 (0.74 to 0.89)”
Quote in the paperSubstantial claim - Premiseown data
In a cohort of 289,573 Chinese women aged 30-79, never breastfeeding compared with breastfeeding was associated with a hazard ratio of 1.00 (95% CI 0.77 to 1.29) for fatal composite cardiovascular disease.
“Fatal composite cardiovascular disease | Never breastfed, HR 1.00 (0.77 to 1.29)”
Quote in the paperNot a substantial claim - Premiseown data
In a cohort of 289,573 Chinese women aged 30-79, lifetime lactation duration 24-36 months compared with never breastfed in parous women was associated with a hazard ratio of 0.91 (95% CI 0.88 to 0.94) for non-fatal stroke.
“Non-fatal stroke | 24-36 months, HR 0.91 (0.88 to 0.94)”
Quote in the paperSubstantial claim - Premisecitation
In a cohort of 8044 parous women, never breastfeeding compared with breastfeeding was associated with a hazard ratio of 1.00 (95% CI 0.75 to 1.34) for non-fatal coronary heart disease.
“Non-fatal coronary heart disease | Never breastfed, HR 1.00 (0.75 to 1.34)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Peters 2016
Not checked in the free run.
- Premiseown data
In a cohort of 289,573 Chinese women aged 30-79, lifetime lactation duration >48 months compared with never breastfed in parous women was associated with a hazard ratio of 0.86 (95% CI 0.79 to 0.92) for fatal composite cardiovascular disease.
“Fatal composite cardiovascular disease | >48 months, HR 0.86 (0.79 to 0.92)”
Quote in the paperSubstantial claim - Premisecitation
Certain reproductive factors, including endometriosis, pelvic inflammatory disease, first trimester bleeding without miscarriage, and anaemia in pregnancy, have been linked to an increased risk of future cardiovascular disease events.
“Certain reproductive factors, including endometriosis, pelvic inflammatory disease, first trimester bleeding without miscarriage, and anaemia in pregnancy, have been linked to an increased risk of future cardiovascular disease events”
Quote in the paperNot a substantial claim0 of 3 sources checked - Study design and conductown data
In some instances, evidence was derived from one study or pooled studies which recorded a small number of events, leading to imprecise results.
“In some instances, evidence was derived from one study or pooled studies which recorded a small number of events, leading to imprecise results”
Quote in the paperNot a substantial claim - Premisecitation
In a cohort of 8044 parous women, lifetime duration of breastfeeding 6-12 months compared with never breastfed was associated with a hazard ratio of 0.69 (95% CI 0.55 to 0.87) for non-fatal coronary heart disease.
“Non-fatal coronary heart disease | 6-12 months HR 0.69 (0.55 to 0.87)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Peters 2016
Not checked in the free run.
- Premisecitation
In a cohort of 8044 parous women, lifetime duration of breastfeeding 12-23 months compared with never breastfed was associated with a hazard ratio of 0.63 (95% CI 0.51 to 0.76) for non-fatal coronary heart disease.
“Non-fatal coronary heart disease | 12-23 months HR 0.63 (0.51 to 0.76)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Peters 2016
Not checked in the free run.
- Study design and conductreasoning
Several reviews could not evaluate the presence of publication bias because of the small number of studies in the meta-analyses.
“Several reviews could not evaluate the presence of publication bias because of the small number of studies in the meta-analyses”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [123] source
Not checked in the free run.
- Study design and conductnone given
Several associations between reproductive factors and cardiovascular disease had a high degree of between study heterogeneity.
“Several associations between reproductive factors and cardiovascular disease had a high degree of between study heterogeneity”
Quote in the paperNot a substantial claim - Premisecitation
Never breastfed was associated with vascular characteristics (larger arterial lumen and adventitial diameters) linked to a higher risk of cardiovascular disease independent of sociodemographic characteristics, health related behaviour, family history, and body mass index.
“never breastfed was associated with vascular characteristics (larger arterial lumen and adventitial diameters) linked to a higher risk of cardiovascular disease independent of sociodemographic characteristics, health related behaviour, family history, and body mass index”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
In a cohort of 8044 parous women, lifetime duration of breastfeeding >23 months compared with never breastfed was associated with a hazard ratio of 0.62 (95% CI 0.45 to 0.86) for non-fatal coronary heart disease.
“Non-fatal coronary heart disease | >23 months HR 0.62 (0.45 to 0.86)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Peters 2016
Not checked in the free run.
- Study design and conductnone given
The evidence in the umbrella review was from observational study designs which are prone to residual confounding.
“The evidence in the umbrella review was from observational study designs which are prone to residual confounding”
Quote in the paperSubstantial claim - Premisecitation
In a cohort of 8044 parous women, lifetime duration of breastfeeding 3-6 months compared with never breastfed was associated with a hazard ratio of 0.68 (95% CI 0.56 to 0.83) for non-fatal coronary heart disease.
“Non-fatal coronary heart disease | 3-6 months HR 0.68 (0.56 to 0.83)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Peters 2016
Not checked in the free run.
- Study design and conductreasoning
Some of the evidence was derived from cross sectional studies which are poor in determining temporal associations.
“some of the evidence was derived from cross sectional studies which are poor in determining temporal associations”
Quote in the paperNot a substantial claim - Premisecitation
Use of hormonal contraceptive agents might result in a homeostasis imbalance by favouring procoagulant factors and decreasing anticoagulant factors.
“Use of hormonal contraceptive agents might result in a homeostasis imbalance by favouring procoagulant factors and decreasing anticoagulant factors”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [139] source
Not checked in the free run.
- Premisecitation
Metabolic derangements linked to the risk of cardiovascular disease, including weight gain, decreased insulin sensitivity, dyslipidaemia, and hypertension, are prevalent in women with risk factors for cardiovascular disease specific to women.
“Metabolic derangements linked to the risk of cardiovascular disease, including weight gain, decreased insulin sensitivity, dyslipidaemia, and hypertension, are prevalent in women with risk factors for cardiovascular disease specific to women”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Parity of four or more is associated with an increased risk of cardiovascular disease through an accelerated atherosclerotic process in both younger and older women.
“Parity of four or more is associated with an increased risk of cardiovascular disease through an accelerated atherosclerotic process in both younger and older women”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [148] source
Not checked in the free run.
- Premisecitation
An analysis reported in another review, which excluded studies with self-reported low birth weight and those that reported less severe forms of cardiovascular disease, revealed a statistically significant association (odds ratio 1.46, 95% CI 1.11 to 1.91) between low birth weight and cardiovascular disease.
“An analysis reported in another review,60 which excluded studies with self-reported low birth weight and those that reported less severe forms of cardiovascular disease, revealed a statistically significant association (odds ratio 1.46, 95% confidence interval 1.11 to 1.91) between low birth weight and cardiovascular disease”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] source
Not checked in the free run.
- Premisecitation
In young women aged 50 or younger, prolonged lactation was inversely linked to risk factors for cardiovascular disease, including total cholesterol, body mass index, waist circumference, and hypertension.
“in young women aged 50 or younger, prolonged lactation was inversely linked to risk factors for cardiovascular disease, including total cholesterol, body mass index, waist circumference, and hypertension”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [146] source
Not checked in the free run.
- Interpretationreasoning
The evidence reported in this umbrella review suggests that, from menarche to menopause, the reproductive profile of women is associated with their future risk of cardiovascular disease.
“the evidence reported in this umbrella review suggests that, from menarche to menopause, the reproductive profile of women is associated with their future risk of cardiovascular disease”
Quote in the paperSubstantial claim - Premisecitation
In an umbrella review, an inverse association between birth weight and future maternal cardiovascular disease was reported (hazard ratio 0.75, 95% CI 0.67 to 0.84, for every one standard deviation increase from the mean weight).
“In an umbrella review,136 an inverse association between birth weight and future maternal cardiovascular disease was reported (hazard ratio 0.75, 95% confidence interval 0.67 to 0.84, for every one standard deviation increase from the mean weight)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [136] source
Not checked in the free run.
- Interpretationcitation
Findings from this review are consistent with European and American evidence based guidelines on prevention of cardiovascular disease that highlighted pre-eclampsia, gestational diabetes, and preterm birth as adverse pregnancy outcomes that potentially increase the risk of cardiovascular disease.
“Findings from our review are consistent with European and American evidence based guidelines on prevention of cardiovascular disease that highlighted pre-eclampsia, gestational diabetes, and preterm birth as adverse pregnancy outcomes that potentially increase the risk of cardiovascular disease”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
A large proportion of women (up to 18% in Europe and North America in 2019) in the reproductive age group use contraceptive pills.
“a large proportion of women (up to 18% in Europe and North America in 2019) in the reproductive age group use contraceptive pills”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [126] United Nations, Department of Economic and Social Affairs, Population Division (2019). Contraceptive use by method 2019: Data Booklet (ST/ESA/SER.A/435). https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/files/documents/2020/Jan/un_2019_contraceptiveusebymethod_databooklet.pdf
Not checked in the free run.
- Premisecitation
A study focusing only on coronary heart disease suggested that 15% of coronary heart disease in women younger than 65 cannot be explained by existing risk factors.
“A study focusing only on coronary heart disease suggested that 15% of coronary heart disease in women younger than 65 cannot be explained by existing risk factors”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [34] source
Not checked in the free run.
- Interpretationcitation
The evidence reported supports the results from an overview of reviews that investigated the association between polycystic ovary syndrome and system wide complications, including cardiovascular disease.
“The evidence reported supports the results from an overview of reviews that investigated the association between polycystic ovary syndrome and system wide complications, including cardiovascular disease”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [68] source
Not checked in the free run.
- Classified as probably not a substantial claim. 49
- May combine two claims. 30
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe included reviews evaluated multiple risk factors over an average follow-up period of 7-10 years.
“32 reviews were included, evaluating multiple risk factors over an average follow-up period of 7-10 years.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenAll except three included reviews were of moderate quality.
“All except three reviews were of moderate quality.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe umbrella review included 32 reviews.
“32 reviews were included, evaluating multiple risk factors over an average follow-up period of 7-10 years.”
- Also stated in: § Study characteristics of reviews with non-overlapping associations · plain
“Of the 32 reviews included in the analyses, 24 conducted meta-analyses as the main form of evidence synthesis.”
Quote in the paperNot a substantial claim- Also stated in: § Study characteristics of reviews with non-overlapping associations · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataPreterm births were investigated in 3 included reviews.
“Adverse pregnancy outcomes included miscarriage (n=1), pre-eclampsia (n=2), gestational diabetes (n=2), preterm births (n=3), and multiple adverse pregnancy outcomes (n=1).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataBreastfeeding was investigated in 1 included review.
“Factors related to fertility investigated in the included reviews were use of hormonal contraceptive agents (n=9), fertility treatment (n=1), early menarche (n=2), polycystic ovary syndrome (n=3), menopause (n=4), parity (n=2), and breastfeeding (n=1).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataMiscarriage was investigated in 1 included review.
“Adverse pregnancy outcomes included miscarriage (n=1), pre-eclampsia (n=2), gestational diabetes (n=2), preterm births (n=3), and multiple adverse pregnancy outcomes (n=1).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataOne study reviewed risk factors related to fertility and adverse pregnancy outcomes but was limited to heart failure as an outcome.
“One study reviewed risk factors related to fertility and adverse pregnancy outcomes but was limited to heart failure as an outcome (n=1).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe median length of follow-up was about 10 years for studies on risk factors related to fertility.
“The median length of follow-up was about 10 years for studies on risk factors related to fertility and 7.5 years for studies on adverse pregnancy outcomes.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataParity was investigated in 2 included reviews.
“Factors related to fertility investigated in the included reviews were use of hormonal contraceptive agents (n=9), fertility treatment (n=1), early menarche (n=2), polycystic ovary syndrome (n=3), menopause (n=4), parity (n=2), and breastfeeding (n=1).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataMenopause was investigated in 4 included reviews.
“Factors related to fertility investigated in the included reviews were use of hormonal contraceptive agents (n=9), fertility treatment (n=1), early menarche (n=2), polycystic ovary syndrome (n=3), menopause (n=4), parity (n=2), and breastfeeding (n=1).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataUse of hormonal contraceptive agents was investigated in 9 included reviews.
“Factors related to fertility investigated in the included reviews were use of hormonal contraceptive agents (n=9), fertility treatment (n=1), early menarche (n=2), polycystic ovary syndrome (n=3), menopause (n=4), parity (n=2), and breastfeeding (n=1).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataMultiple adverse pregnancy outcomes were investigated in 1 included review.
“Adverse pregnancy outcomes included miscarriage (n=1), pre-eclampsia (n=2), gestational diabetes (n=2), preterm births (n=3), and multiple adverse pregnancy outcomes (n=1).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataPre-eclampsia was investigated in 2 included reviews.
“Adverse pregnancy outcomes included miscarriage (n=1), pre-eclampsia (n=2), gestational diabetes (n=2), preterm births (n=3), and multiple adverse pregnancy outcomes (n=1).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThirty-two reviews were rated as moderate in quality and seven reviews were rated as low in quality.
“Thirty two reviews were rated as moderate in quality and seven reviews were rated as low in quality (appendix 7).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataGestational diabetes was investigated in 2 included reviews.
“Adverse pregnancy outcomes included miscarriage (n=1), pre-eclampsia (n=2), gestational diabetes (n=2), preterm births (n=3), and multiple adverse pregnancy outcomes (n=1).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataEarly menarche was investigated in 2 included reviews.
“Factors related to fertility investigated in the included reviews were use of hormonal contraceptive agents (n=9), fertility treatment (n=1), early menarche (n=2), polycystic ovary syndrome (n=3), menopause (n=4), parity (n=2), and breastfeeding (n=1).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe median length of follow-up was about 7.5 years for studies on adverse pregnancy outcomes.
“The median length of follow-up was about 10 years for studies on risk factors related to fertility and 7.5 years for studies on adverse pregnancy outcomes.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataFertility treatment was investigated in 1 included review.
“Factors related to fertility investigated in the included reviews were use of hormonal contraceptive agents (n=9), fertility treatment (n=1), early menarche (n=2), polycystic ovary syndrome (n=3), menopause (n=4), parity (n=2), and breastfeeding (n=1).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataPolycystic ovary syndrome was investigated in 3 included reviews.
“Factors related to fertility investigated in the included reviews were use of hormonal contraceptive agents (n=9), fertility treatment (n=1), early menarche (n=2), polycystic ovary syndrome (n=3), menopause (n=4), parity (n=2), and breastfeeding (n=1).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataOf the 32 reviews included in the analyses, 24 conducted meta-analyses as the main form of evidence synthesis.
“Of the 32 reviews included in the analyses, 24 conducted meta-analyses as the main form of evidence synthesis.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationThe risk of myocardial infarction or stroke with combined oral contraceptives is increased in women on higher doses of oestrogen but is not related to the dose, generation, or type of progesterone.
“The same review55 showed that the risk was increased in women on higher doses of oestrogen but was not related to the dose, generation, or type of progesterone (supplementary table 3).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55] source
Not checked in the free run.
May combine two claims.
Findingown dataThe risk of both ischaemic and haemorrhagic stroke is greatest in women on higher doses of oestrogen, who had hypertension, were smokers, or were aged over 35.
“The risk of both ischaemic and haemorrhagic stroke was greatest in women on higher doses of oestrogen, who had hypertension, were smokers, or were aged over 35 (supplementary table 3).”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationWhen the analysis is limited to women who did not go on to develop diabetes mellitus after gestational diabetes, the risk of composite cardiovascular disease is slightly less but remains statistically significant.
“When the analysis was limited to women who did not go on to develop diabetes mellitus after gestational diabetes, the risk was slightly less but remained statistically significant (supplementary table 3).62”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [62] source
Not checked in the free run.
May combine two claims.
FindingcitationCurrent use of combined oral contraceptives (oestrogen and progesterone), premature ovarian insufficiency, early menopause, and recurrent miscarriage were associated with a 1.5-1.9-fold increased risk of ischaemic heart disease.
“current use of combined oral contraceptives (oestrogen and progesterone), premature ovarian insufficiency, early menopause, and recurrent miscarriage were associated with a 1.5-1.9-fold increased risk”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCurrent use of any oral contraceptives (combined oral contraceptives and progesterone only pill), recurrent pre-eclampsia, and pre-eclampsia were associated with a twofold or more increased risk of stroke.
“Current use of any oral contraceptives (combined oral contraceptives and progesterone only pill), recurrent pre-eclampsia, and pre-eclampsia were associated with a twofold or more increased risk of stroke”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSystematic reviews on endometriosis, pelvic inflammatory disease, first trimester bleeding without miscarriage, and anaemia in pregnancy could not be identified, and therefore these factors were not incorporated in the analyses.
“Systematic reviews on these exposures could not be identified, however, and therefore these factors were not incorporated in our analyses”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCurrent use of combined oral contraceptives, use of combined hormonal contraceptive agents in women with dyslipidaemia, use of combined hormonal contraceptive agents in women with hypertension, use of oestrogen containing pills in women with migraine, polycystic ovary syndrome, premature ovarian insufficiency, early menarche, early menopause, menopausal symptoms, parity, pre-eclampsia, recurrent预e
“Evidence from the umbrella review suggests that current use of combined oral contraceptives, use of combined hormonal contraceptive agents in women with dyslipidaemia, use of combined hormonal contraceptive agents in women with hypertension, use of oestrogen containing pills in women with migraine, polycystic ovary syndrome, premature ovarian insufficiency, early menarche, early menopause, menop”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMaternal delivery of preterm infants, gestational diabetes, and current use of combined oral contraceptives were associated with a 1.5-1.9-fold increase in risk of stroke.
“maternal delivery of preterm infants, gestational diabetes, and current use of combined oral contraceptives were associated with a 1.5-1.9-fold increase in risk”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenReviews on endometriosis, pelvic inflammatory disease, and anaemia during pregnancy were absent.
“Reviews on endometriosis, pelvic inflammatory disease, and anaemia during pregnancy were absent”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationA history of maternal delivery of preterm infants, gestational diabetes, pre-eclampsia, and recurrent pre-eclampsia were associated with a twofold or more increase in the risk of ischaemic heart disease.
“A history of maternal delivery of preterm infants, gestational diabetes, pre-eclampsia, and recurrent pre-eclampsia were associated with a twofold or more increase in the risk of ischaemic heart disease”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Findingnone givenThis study provides a comprehensive list of factors related to reproduction and adverse pregnancy outcomes and their association with cardiovascular disease.
“This study provides a comprehensive list of factors related to reproduction and adverse pregnancy outcomes and their association with cardiovascular disease”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe increased risk of composite cardiovascular disease but not stroke was statistically significant (odds ratio 1.67, 95% confidence interval 1.28 to 2.19) in women with gestational hypertension.
“We reported that the increased risk of composite cardiovascular disease but not stroke was statistically significant (odds ratio 1.67, 95% confidence interval 1.28 to 2.19) in women with gestational hypertension”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThis review reports evidence of an increased risk of cardiovascular disease outcomes in women with stillbirths, small for gestational age offspring, and placental abruption.
“this review reports evidence of an increased risk of cardiovascular disease outcomes in women with stillbirths, small for gestational age offspring, and placental abruption”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe evidence evaluated reported an increased risk of ischaemic heart disease and cardiovascular disease associated with premature menopause.
“the evidence we evaluated reported an increased risk of ischaemic heart disease and cardiovascular disease associated with premature menopause”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenEarly menopause and menopausal symptoms were associated with an increased risk of ischaemic heart disease.
“early menopause and menopausal symptoms were associated with an increased risk of ischaemic heart disease”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable). May combine two claims.
Findingnone givenThe review provides clarity on the quality of the evidence, identifies gaps in evidence and practice, and provides recommendations that could be incorporated into guidelines.
“The review provides clarity on the quality of the evidence, identifies gaps in evidence and practice, and provides recommendations that could be incorporated into guidelines”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenDisagreements in quality assessment were resolved by consulting a third reviewer.
“In the case of disagreements and failed consensus, a decision was reached by consulting a third reviewer (NJA).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenTwo reviewers independently carried out study selection and data extraction.
“Two reviewers (KO and JSC) independently carried out the study selection and data extraction from the eligible studies.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe study used the data extraction form recommended by the Joanna Briggs Institute.
“The study used the data extraction form recommended by the Joanna Briggs Institute (appendix 2).42”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] Aromataris E Fernandez R Godfrey C Holly C Khalil H Tungpunkom P . Methodology for JBI umbrella reviews. Joanna Briggs Inst Rev Man, 2014:1-34.
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationCCA is a validated method of quantifying the degree of overlap between two or more reviews.
“CCA is a validated method of quantifying the degree of overlap between two or more reviews, and helps the decision process on how to deal with overlap when it is present.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [45] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe protocol was registered in PROSPERO (registration No CRD42019120076).
“The umbrella review followed the guidelines for Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), and the protocol was registered in PROSPERO (registration No CRD42019120076).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenTwo reviewers independently rated the methodological quality of the reviews with the AMSTAR 2 quality appraisal instrument.
“Two reviewers (KO and JSC) rated the methodological quality of the reviews with the AMSTAR 2 quality appraisal instrument.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe umbrella review followed PRISMA guidelines.
“The umbrella review followed the guidelines for Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), and the protocol was registered in PROSPERO (registration No CRD42019120076).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe review of polycystic ovary syndrome in postmenopausal women was rated as low quality.
“Results from population based studies suggested that, compared with healthy controls, the risk of cardiovascular events was increased in young women in the reproductive age group with polycystic ovary syndrome (hazard ratio 1.43, 95% confidence interval 1.27 to 1.61); no association was seen in postmenopausal women with polycystic ovary syndrome (supplementary table 3)70 but this review was rated”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [70] Ramezani Tehrani, 2019, Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis, Gynecol Endocrinol
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataA small degree (CCA 5.6%) of overlap was noted between two reviews investigating the association between pre-eclampsia and risk of morbidity from ischaemic heart disease.
“A small degree (CCA 5.6%) of overlap was noted between two reviews60 61 that investigated the association between pre-eclampsia and the risk of morbidity from ischaemic heart disease (appendix 3).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationOne review searched for primary studies from 2005 only.
“One review61 searched for primary studies from 2005 only.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe quality of the newly published breastfeeding studies ranged from low to high.
“The quality of the studies ranged from low to high (appendix 10).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenMethodological rigour in the conduct of the review was achieved by following PRISMA guidelines.
“Methodological rigour in the conduct of the review was achieved by following PRISMA guidelines”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductnone givenWith the AMSTAR 2 quality appraisal instrument, some reviews were rated as low quality, and none of the reviews was rated as high in quality.
“With the AMSTAR 2 quality appraisal instrument, some reviews were rated as low quality, and none of the reviews was rated as high in quality”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductcitationThe reviews included were necessarily based on observational evidence; consequently, the possibility of confounding remains because of unknown confounders or lack of adjustment for known confounders.
“the reviews included were necessarily based on observational evidence; consequently, as noted by Grandi et al,60 the possibility of confounding remains because of unknown confounders or lack of adjustment for known confounders”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe methodological quality of the studies included in the review was assessed with the AMSTAR 2 tool.
“The methodological quality of the studies included in the review was assessed with the AMSTAR 2 tool”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenMisclassification of exposure or outcome status in the studies included in the review is possible.
“Misclassification of exposure or outcome status in the studies included in the review is also possible”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductcitationFor some reproductive factors, including age at first birth, evidence from a systematic review was identified, but because of inherent methodological shortcomings, the review did not meet the inclusion criteria.
“for some reproductive factors, including age at first birth,122 evidence from a systematic review was identified, but because of inherent methodological shortcomings,40 the review did not meet our inclusion criteria”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationEvidence presented in this review on combined hormonal contraceptive agents and combined oral contraceptives is in keeping with findings on the adverse effects of the use of hormonal contraceptive agents reported in current evidence based guidelines.
“Evidence presented in this review on combined hormonal contraceptive agents and combined oral contraceptives are in keeping with findings on the adverse effects of the use of hormonal contraceptive agents reported in current evidence based guidelines”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [124] FSRH Clinical Guideline. Combined hormonal contraception (January 2019, amended July 2019) - Faculty of Sexual and Reproductive Healthcare. 2019. https://www.fsrh.org/standards-and-guidance/documents/combined-hormonal-contraception/
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationThe findings of this review agree with the consensus statement from the European Headache Federation, which reported that the risk of stroke was greater in women with migraine.
“the findings of this review agree with the consensus statement from the European Headache Federation, which reported that the risk of stroke was greater in women with migraine”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [125]
Not checked in the free run.
May combine two claims.
Study design and conductnone givenInformation from some of the primary studies was self-reported, which might lead to potential misclassification and recall bias.
“Information from some of the primary studies was self-reported, which might lead to potential misclassification and recall bias”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenLack of data, including missing metadata (number of participants and events), hindered the reporting of some elements of the umbrella review.
“Lack of data, including missing metadata (number of participants and events), hindered the reporting of some elements of the umbrella review”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningInsufficient reporting by review authors rather than shortcomings of the review methods could have inadvertently led to a downgrading of the quality of the review.
“Insufficient reporting by review authors rather than shortcomings of the review methods could have inadvertently led to a downgrading of the quality of the review”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenWhere eligible, reviews were updated to ensure the evidence was current.
“Where eligible, reviews were updated to ensure the evidence was current”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe absolute risk of cardiovascular disease associated with the use of combined oral contraceptives is low (about 10 per 100 000 person years for myocardial infarction and 21 per 100 000 person years for stroke).
“the absolute risk of cardiovascular disease associated with the use of combined oral contraceptives is low (about 10 per 100 000 person years for myocardial infarction and 21 per 100 000 person years for stroke)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenA comprehensive search strategy was used to identify relevant reviews.
“A comprehensive search strategy was used to identify relevant reviews”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenEvaluation of CCA and reporting of the highest quality and most current review from reviews with overlapping associations were used to eliminate double counting.
“Evaluation of CCA and reporting of the highest quality and most current review from reviews with overlapping associations were used to eliminate double counting”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationOur previous study found insufficient reporting of gestational diabetes and screening for cardiovascular risk factors in these women.
“Our previous study found insufficient reporting of gestational diabetes and screening for cardiovascular risk factors in these women”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [108] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationA meta-analysis published beyond the time line of this review reported that women with gestational hypertension had an increased risk of composite cardiovascular disease (relative risk 1.73, 95% CI 1.43 to 2.09), stroke (1.66, 0.99 to 2.79), coronary heart disease (1.56, 1.35 to 1.81), and heart failure (1.70, 1.43 to 2.02).
“a meta-analysis,135 published beyond the time line of this review, which reported that women with gestational hypertension had an increased risk of composite cardiovascular disease (relative risk 1.73, 95% confidence interval 1.43 to 2.09), stroke (1.66, 0.99 to 2.79), coronary heart disease (1.56, 1.35 to 1.81), and heart failure (1.70, 1.43 to 2.02)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [135] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationHospital episodes related to cardiovascular disease occurred in 381 458 women in the financial year 2017-18, indicating an incidence of about 113.4 cardiovascular disease episodes per 10 000 women annually.
“Hospital episodes related to cardiovascular disease occurred in 381 458 women in the financial year 2017-18,151 indicating an incidence of about 113.4 cardiovascular disease episodes per 10 000 women annually”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [151] 2019, Heart and circulatory disease statistics 2019, Stat Compend
Not checked in the free run.
May combine two claims.
Study design and conductown dataResults on the risk of heart failure were based on one cross sectional study that reported imprecise results.
“Results on the risk of heart failure were based on one cross sectional study that reported imprecise results”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenCross sectional studies cannot be used to infer causality.
“cross sectional studies cannot be used to infer causality”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S4 (based). May combine two claims.
Premisenone givenClarity on the quality of the evidence is lacking and on how the findings can be translated into public health and clinical practice.
“Clarity on the quality of the evidence is lacking and on how the findings can be translated into public health and clinical practice”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningA large proportion of unexplained risk of cardiovascular disease in women might be attributable to reproductive risk factors but the exact magnitude of the effect is unclear.
“A large proportion of unexplained risk of cardiovascular disease in women might be attributable to reproductive risk factors but the exact magnitude of the effect is unclear”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenIndividual reviews assessing the implications of these risk factors for cardiovascular disease have been published.
“Individual reviews assessing the implications of these risk factors for cardiovascular disease have been published”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationEndothelial dysfunction, which has been found in women with premature menopause and in those with adverse pregnancy outcomes, might trigger pregnancy complications and remain beyond these complications to predispose women to future cardiovascular disease.
“Endothelial dysfunction, which has been found in women with premature menopause and in those with adverse pregnancy outcomes, might trigger pregnancy complications and remain beyond these complications to predispose women to future cardiovascular disease”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGuidelines on the prevention of cardiovascular disease recognise perimenopause and menopause as periods when women are vulnerable to cardiovascular disease.
“Guidelines on the prevention of cardiovascular disease recognise perimenopause and menopause as periods when women are vulnerable to cardiovascular disease”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S4 (based).
Premisenone givenRisk factors specific to women are associated with cardiovascular disease.
“Risk factors specific to women are associated with cardiovascular disease”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationFamilies of women with a history of reproductive complications were also at an increased risk of cardiovascular disease and so genetic predispositions could have a role.
“Families of women with a history of reproductive complications were also at an increased risk of cardiovascular disease and so genetic predispositions could have a role”
Quote in the paperNot a substantial claim0 of 2 sources checked
The paper relies on this without support.
The associations between reproductive factors and cardiovascular disease observed in the included observational studies are not entirely due to residual confounding.
“the reviews included were necessarily based on observational evidence; consequently, as noted by Grandi et al,60 the possibility of confounding remains because of unknown confounders or lack of adjustment for known confounders”
The paper relies on this without support.
The included systematic reviews and meta-analyses provide valid estimates of the associations between reproductive factors and cardiovascular disease.
“This detailed umbrella review synthesised existing systematic reviews and meta-analyses into one user friendly document”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
These inflammatory changes are relevant as regards the cardiovascular morbidity related to COC use compared to progestin-only preparations.
“These inflammatory changes are relevant as regards the cardiovascular morbidity related to COC use compared to progestin-only preparations, as shown in a recent review (Okoth et al., 2020).”
From Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial (2023) · cites this paper as Okoth et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Parity and non-fatal cardiovascular disease have opposite directions in the text and table
MajorThe text says non-fatal cardiovascular disease risk was increased in ever-parous women, but Table 1 reports a relative risk of 0.79 for non-fatal composite cardiovascular disease under parity.
“For non-fatal events,90 however, the risk of composite cardiovascular disease was increased in ever parous women, with the risk increasing by 4% for each live birth.90”
“| Non-fatal | RR 0.79 (0.60 to 1.06) | — | — | — |”
Recurrent pre-eclampsia-stroke association is described as twofold or greater
MajorThe abstract places recurrent pre-eclampsia in the twofold-or-greater stroke-risk category, but Table 1 reports a relative risk of 1.69.
“twofold or more for current use of any oral contraceptive (combined oral contraceptives or progesterone only pill), pre-eclampsia, and recurrent pre-eclampsia”
“| Non-fatal | — | RR 2.40 (2.15 to 2.68) | RR 1.69 (1.21 to 2.35) | RR 2.88 (2.23 to 3.72) |”
Breastfeeding comparison misstates a cohort study's reference group
MinorThe text says all three cited cohorts compared longer breastfeeding with never breastfeeding. Table 2 instead shows that study 114 used breastfeeding for less than four months as its reference group.
“A longer length of breastfeeding was associated with a reduced risk of non-fatal composite cardiovascular disease compared with never breastfed in all three cohort studies.111 114 116”
“| To examine how any, partial, and full breastfeeding duration are associated with maternal risk of hypertension and cardiovascular disease and how pre-pregnancy body mass index and waist circumference influence the association | Cohort study of 63 260 women with liveborn singleton infants | Breastfeeding for less than 4 months v breastfeeding for >4 months (pre-pregnancy normal/underweight) | Non-fatal cardiovascular disease (18 months-15 years postpartum) | <4 months (reference) |”
Gestational diabetes-stroke association is assigned the wrong effect-size category
MinorThe abstract places gestational diabetes in the 1.5-1.9-fold stroke-risk category, whereas Table 1 reports a relative risk of 1.25.
“1.5-1.9-fold for current use of combined oral contraceptives, gestational diabetes, and preterm birth”
“| Non-fatal | — | RR 2.09 (1.56 to 2.80) | RR 1.25 (1.07 to 1.48) | — |”
Cites
Shea, B. J., Reeves, B. C., Wells, G., Thuku, M., Hamel, C., Moran, J., Moher, D., Tugwell, P., Welch, V., Kristjansson, E., et al. (2017) · BMJ · doi:10.1136/bmj.j4008 · Cited by 10,636 · see citing works
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490 · see citing works
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709 · see citing works
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457 · see citing works
(2019) · doi:10.1161/cir.0000000000000677 · Cited by 4,501 · see citing works
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. J. (2007) · BMJ · doi:10.1136/bmj.39335.385301.be · Cited by 2,552 · see citing works
Mascarenhas, M., Flaxman, S. R., Boerma, T., Vanderpoel, S., & Stevens, G. A. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001356 · Cited by 2,357 · see citing works
Mosca, L., Benjamin, E. J., Berra, K., Bezanson, J. L., Dolor, R. J., Lloyd-Jones, D. M., Newby, L. K., Piña, I. L., Roger, V. L., Shaw, L. J., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820faaf8 · Cited by 2,143 · see citing works
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.010 · Cited by 1,896 · see citing works
Huxley, R., Barzi, F., & Woodward, M. (2005) · BMJ · doi:10.1136/bmj.38678.389583.7c · Cited by 1,531 · see citing works
Prevalence of Conventional Risk Factors in Patients With Coronary Heart Disease
Khot, U. N. (2003) · JAMA · doi:10.1001/jama.290.7.898 · Cited by 1,494 · see citing works
Systematic review finds overlapping reviews were not mentioned in every other overview
Pieper, D., Antoine, S.-L., Mathes, T., Neugebauer, E. A. M., & Eikermann, M. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.11.007 · Cited by 1,318 · see citing works
Methodology in conducting a systematic review of systematic reviews of healthcare interventions
Smith, V., Devane, D., Begley, C. M., & Clarke, M. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-15 · Cited by 1,227 · see citing works
Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis
Wu, P., Haththotuwa, R., Kwok, C. S., Babu, A., Kotronias, R. A., Rushton, C., Zaman, A., Fryer, A. A., Kadam, U., Chew-Graham, C. A., et al. (2017) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.116.003497 · Cited by 1,147 · see citing works
Ray, J. G., Vermeulen, M. J., Schull, M. J., & Redelmeier, D. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67726-4 · Cited by 1,013 · see citing works
Kramer, C. K., Campbell, S., & Retnakaran, R. (2019) · Diabetologia · doi:10.1007/s00125-019-4840-2 · Cited by 965 · see citing works
Bushnell, C., McCullough, L. D., Awad, I. A., Chireau, M. V., Fedder, W. N., Furie, K. L., Howard, V. J., Lichtman, J. H., Lisabeth, L. D., Piña, I. L., et al. (2014) · Stroke · doi:10.1161/01.str.0000442009.06663.48 · Cited by 941 · see citing works
Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis
Ananth, C. V., Keyes, K. M., & Wapner, R. J. (2013) · BMJ · doi:10.1136/bmj.f6564 · Cited by 940 · see citing works
How Quickly Do Systematic Reviews Go Out of Date? A Survival Analysis
Shojania, K. G., Sampson, M., Ansari, M. T., Ji, J., Doucette, S., & Moher, D. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-4-200708210-00179 · Cited by 838 · see citing works
Muka, T., Oliver-Williams, C., Kunutsor, S., Laven, J. S. E., Fauser, B. C. J. M., Chowdhury, R., Kavousi, M., & Franco, O. H. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2415 · Cited by 826 · see citing works
Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction
Arora, S., Stouffer, G. A., Kucharska‐Newton, A., Qamar, A., Vaduganathan, M., Pandey, A., Porterfield, D. S., Blankstein, R., Rosamond, W. D., Bhatt, D. L., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.037137 · Cited by 763 · see citing works
Roberge, S., Nicolaides, K., Demers, S., Hyett, J., Chaillet, N., & Bujold, E. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.09.076 · Cited by 679 · see citing works
Smoking and risk of myocardial infarction in women and men: longitudinal population study
Prescott, E., Hippe, M., Schnohr, P., Hein, H. O., & Vestbo, J. (1998) · BMJ · doi:10.1136/bmj.316.7137.1043 · Cited by 660 · see citing works
Grandi, S. M., Filion, K. B., Yoon, S., Ayele, H. T., Doyle, C. M., Hutcheon, J. A., Smith, G. N., Gore, G. C., Ray, J. G., Nerenberg, K., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036748 · Cited by 610 · see citing works
Thrombotic stroke and myocardial infarction with hormonal contraception
Lidegaard, Ø., Løkkegaard, E., Jensen, A., Skovlund, C. W., & Keiding, N. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1111840 · Cited by 607 · see citing works
Coronary Heart Disease Mortality Among Young Adults in the U.S. From 1980 Through 2002
Ford, E. S., & Capewell, S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.05.056 · Cited by 589 · see citing works
The Epidemiology of Adverse Pregnancy Outcomes: An Overview
Kramer, M. S. (2003) · Journal of Nutrition · doi:10.1093/jn/133.5.1592s · Cited by 546 · see citing works
Wilmot, K. A., O’Flaherty, M., Capewell, S., Ford, E. S., & Vaccarino, V. (2015) · Circulation · doi:10.1161/circulationaha.115.015293 · Cited by 522 · see citing works
Handbook of Life Course Health Development
Halfon, N., Forrest, C. B., Lerner, R. M., & Faustman, E. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-47143-3 · Cited by 522 · see citing works
Gupta, A., Wang, Y., Spertus, J. A., Geda, M. E., Lorenze, N. P., Nkonde-Price, C., D’Onofrio, G., Lichtman, J. H., & Krumholz, H. M. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.054 · Cited by 509 · see citing works
Duration of Lactation and Risk Factors for Maternal Cardiovascular Disease
Schwarz, E. B., Ray, R. M., Stuebe, A. M., Allison, M. A., Ness, R. B., Freiberg, M. S., & Cauley, J. A. (2009) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000346884.67796.ca · Cited by 436 · see citing works
When and how to update systematic reviews: consensus and checklist
Garner, P., Hopewell, S., Chandler, J., MacLehose, H., Schünemann, H. J., Akl, E. A., Beyene, J., Chang, S., Churchill, R., Dearness, K., et al. (2016) · BMJ · doi:10.1136/bmj.i3507 · Cited by 426 · see citing works
Prentice, P., & Viner, R. M. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.177 · Cited by 418 · see citing works
Rich-Edwards, J. W., Fraser, A., Lawlor, D. A., & Catov, J. M. (2014) · Epidemiologic Reviews · doi:10.1093/epirev/mxt006 · Cited by 417 · see citing works
Fraser, A., Nelson, S. M., Macdonald-Wallis, C., Cherry, L., Butler, E., Sattar, N., & Lawlor, D. A. (2012) · Circulation · doi:10.1161/circulationaha.111.044784 · Cited by 401 · see citing works
de Groot, P. C. M., Dekkers, O. M., Romijn, J. A., Dieben, S. W. M., & Helmerhorst, F. M. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr001 · Cited by 394 · see citing works
Oral Contraceptives and the Risk of Myocardial Infarction
Tanis, B. C., van den Bosch, M. A. A. J., Kemmeren, J. M., Cats, V. M., Helmerhorst, F. M., Algra, A., van der Graaf, Y., & Rosendaal, F. R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003216 · Cited by 367 · see citing works
Carr, D. B., Utzschneider, K. M., Hull, R. L., Tong, J., Wallace, T. M., Kodama, K., Shofer, J. B., Heckbert, S. R., Boyko, E. J., Fujimoto, W. Y., et al. (2006) · Diabetes Care · doi:10.2337/dc05-2482 · Cited by 350 · see citing works
Pregnancy: a stress test for life
Williams, D. J. (2003) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-200312000-00002 · Cited by 346 · see citing works
Daly, B., Toulis, K. A., Thomas, N., Gokhale, K., Martin, J., Webber, J., Keerthy, D., Jolly, K., Saravanan, P., & Nirantharakumar, K. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002488 · Cited by 328 · see citing works
Self-citationTobias, D. K., Stuart, J. J., Li, S., Chavarro, J., Rimm, E. B., Rich-Edwards, J., Hu, F. B., Manson, J. E., & Zhang, C. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.2790 · Cited by 323 · see citing works
Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke
Roach, R. E. J., Helmerhorst, F. M., Lijfering, W. M., Stijnen, T., Algra, A., & Dekkers, O. M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011054.pub2 · Cited by 299 · see citing works
Thrombotic Stroke and Myocardial Infarction With Hormonal Contraception
Lidegaard, Ø., Løkkegaard, E., Jensen, A., Skovlund, C. W., & Keiding, N. (2012) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000422965.64164.ac · Cited by 292 · see citing works
Kalantaridou, S. N., Naka, K. K., Papanikolaou, E., Kazakos, N., Kravariti, M., Calis, K. A., Paraskevaidis, E. A., Sideris, D. A., Tsatsoulis, A., Chrousos, G. P., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0015 · Cited by 284 · see citing works
Germain, A. M., Romanik, M. C., Guerra, I., Solari, S., Reyes, M. S., Johnson, R. J., Price, K., Karumanchi, S. A., & Valdés, G. (2007) · Hypertension · doi:10.1161/01.hyp.0000251522.18094.d4 · Cited by 275 · see citing works
Lavery, J., Friedman, A., Keyes, K., Wright, J., & Ananth, C. (2017) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14236 · Cited by 275 · see citing works
Roeters van Lennep, J. E., Heida, K. Y., Bots, M. L., Hoek, A., & on behalf of the collaborators of the Dutch Multidisciplinary Guideline Development Group on Cardiovascular Risk Management after Reproductive Disorders (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487314556004 · Cited by 273 · see citing works
Progestin-only contraception and thromboembolism: A systematic review
Tepper, N. K., Whiteman, M. K., Marchbanks, P. A., James, A., & Curtis, K. M. (2016) · Contraception · doi:10.1016/j.contraception.2016.04.014 · Cited by 273 · see citing works
Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women
Michos, E. D., Nasir, K., Braunstein, J. B., Rumberger, J. A., Budoff, M. J., Post, W. S., & Blumenthal, R. S. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.04.004 · Cited by 271 · see citing works
Sex differences in cardiovascular disease – Impact on care and outcomes
Humphries, K. H., Izadnegahdar, M., Sedlak, T., Saw, J., Johnston, N., Schenck-Gustafsson, K. G., Shah, R. U., Regitz‐Zagrosek, V., Grewal, J., Vaccarino, V., et al. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.04.001 · Cited by 271 · see citing works
Charalampopoulos, D., McLoughlin, A., Elks, C. E., & Ong, K. K. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu113 · Cited by 267 · see citing works
Knowledge, Attitudes, and Beliefs Regarding Cardiovascular Disease in Women
Bairey Merz, C. N., Andersen, H., Sprague, E., Burns, A., Keida, M., Walsh, M. N., Greenberger, P., Campbell, S., Pollin, I., McCullough, C., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.024 · Cited by 267 · see citing works
Bougioukas, K. I., Liakos, A., Tsapas, A., Ntzani, E., & Haidich, A.-B. (2018) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.10.002 · Cited by 251 · see citing works
Brouwers, L., van der Meiden‐van Roest, A., Savelkoul, C., Vogelvang, T., Lely, A., Franx, A., & van Rijn, B. (2018) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15394 · Cited by 247 · see citing works
Belbasis, L., Savvidou, M. D., Kanu, C., Evangelou, E., & Tzoulaki, I. (2016) · BMC Medicine · doi:10.1186/s12916-016-0692-5 · Cited by 237 · see citing works
Endometriosis and Risk of Coronary Heart Disease
Mu, F., Rich-Edwards, J., Rimm, E. B., Spiegelman, D., & Missmer, S. A. (2016) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002224 · Cited by 235 · see citing works
Oral Contraceptives and the Risk of Myocardial Infarction
Tanis, B. C., van den Bosch, M. A. A. J., Kemmeren, J. M., Cats, V. M., Helmerhorst, F. M., Algra, A., van der Graaf, Y., & Rosendaal, F. R. (2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200205000-00021 · Cited by 225 · see citing works
Wu, P., Gulati, M., Kwok, C. S., Wong, C. W., Narain, A., O'Brien, S., Chew‐Graham, C. A., Verma, G., Kadam, U. T., & Mamas, M. A. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007809 · Cited by 204 · see citing works
Overstating the evidence – double counting in meta-analysis and related problems
Senn, S. J. (2009) · BMC Medical Research Methodology · doi:10.1186/1471-2288-9-10 · Cited by 199 · see citing works
Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008
Zhang, F., Dong, L., Zhang, C. P., Li, B., Wen, J.-J., Gao, W. Y., Sun, S., Lv, F., Tian, H., Tuomilehto, J. O., et al. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03205.x · Cited by 194 · see citing works
on behalf of the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC), Sacco, S., Merki‐Feld, G. S., Ægidius, K. L., Bitzer, J., Canonico, M., Kurth, T., Lampl, C., Lidegaard, Ø., MacGregor, E. A., et al. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-017-0815-1 · Cited by 193 · see citing works
Contraceptivos orales y riesgo de infarto de miocardio
Tanis, B. C. (2001) · New England Journal of Medicine · Cited by 192 · see citing works
Trends in Acute Ischemic Stroke Hospitalizations in the United States
Ramírez, L., Kim‐Tenser, M. A., Sanossian, N., Cen, S., Wen, G., He, S., Mack, W. J., & Towfighi, A. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003233 · Cited by 188 · see citing works
Duration of lactation and incidence of myocardial infarction in middle to late adulthood
Stuebe, A. M., Michels, K. B., Willett, W. C., Manson, J. E., Rexrode, K., & Rich-Edwards, J. W. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.10.001 · Cited by 187 · see citing works
Coagulation effects of oral contraception
Bonnar, J. (1987) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(87)80129-1 · Cited by 184 · see citing works
Arnett, D. K., Khera, A., & Blumenthal, R. S. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.2604 · Cited by 182 · see citing works
Adverse pregnancy outcomes and future maternal cardiovascular disease
Hauspurg, A., Ying, W., Hubel, C. A., Michos, E. D., & Ouyang, P. (2018) · Clinical Cardiology · doi:10.1002/clc.22887 · Cited by 179 · see citing works
Nasir, K., Michos, E. D., Blumenthal, R. S., & Raggi, P. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.052 · Cited by 177 · see citing works
Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis.
Zhao, L., Zhu, Z., Lou, H., Zhu, G., Huang, W., Zhang, S., & Liu, F. (2016) · Oncotarget · doi:10.18632/oncotarget.9553 · Cited by 174 · see citing works
Gambacciani, M., Ciaponi, M., Cappagli, B., De Simone, L., Orlandi, R., & Genazzani, A. R. (2001) · Maturitas · doi:10.1016/s0378-5122(01)00194-3 · Cited by 173 · see citing works
Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews
Gilbert, E. W., Tay, C. T., Hiam, D. S., Teede, H. J., & Moran, L. J. (2018) · Clinical Endocrinology · doi:10.1111/cen.13828 · Cited by 166 · see citing works
Muka, T., Oliver-Williams, C., Colpani, V., Kunutsor, S., Chowdhury, S., Chowdhury, R., Kavousi, M., & Franco, O. H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0157417 · Cited by 155 · see citing works
Heida, K. Y., Bots, M. L., de Groot, C. J., van Dunné, F. M., Hammoud, N. M., Hoek, A., Laven, J. S., Maas, A. H., Roeters van Lennep, J. E., Velthuis, B. K., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316659573 · Cited by 153 · see citing works
An optimal search filter for retrieving systematic reviews and meta-analyses
Lee, E. H. M., Dobbins, M., DeCorby, K., McRae, L., Tirilis, D., & Husson, H. (2012) · BMC Medical Research Methodology · doi:10.1186/1471-2288-12-51 · Cited by 151 · see citing works
Miscarriage and future maternal cardiovascular disease: a systematic review and meta-analysis
Oliver-Williams, C. T., Heydon, E. E., Smith, G. C. S., & Wood, A. M. (2013) · Heart · doi:10.1136/heartjnl-2012-303237 · Cited by 151 · see citing works
Griffith, R. J., Alsweiler, J., Moore, A. E., Brown, S., Middleton, P., Shepherd, E., & Crowther, C. A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012394.pub3 · Cited by 149 · see citing works
Effect of primary ovarian insufficiency and early natural menopause on mortality: a meta-analysis
Tao, X.-Y., Zuo, A.-Z., Wang, J.-Q., & Tao, F.-B. (2016) · Climacteric · doi:10.3109/13697137.2015.1094784 · Cited by 147 · see citing works
Izadnegahdar, M., Singer, J., Lee, M. K., Gao, M., Thompson, C., Kopec, J. A., & Humphries, K. H. (2013) · Journal of Women s Health · doi:10.1089/jwh.2013.4507 · Cited by 146 · see citing works
Risk of Acute Thromboembolic Events With Oral Contraceptive Use
Urrutia, R. P., Coeytaux, R. R., McBroom, A. J., Gierisch, J. M., Havrilesky, L. J., Moorman, P. G., Lowery, W. J., Dinan, M. A., Hasselblad, V., Sanders, G. D., et al. (2013) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3182994c43 · Cited by 145 · see citing works
Breastfeeding and maternal cardiovascular risk factors and outcomes: A systematic review
Nguyen, B., Jin, K., & Ding, D. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187923 · Cited by 145 · see citing works
Early cardiovascular events in women with a history of gestational diabetes mellitus
Goueslard, K., Cottenet, J., Mariet, A., Giroud, M., Cottin, Y., Petit, J., & Quantin, C. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0338-0 · Cited by 144 · see citing works
Acute coronary syndrome in women: rising hospitalizations in middle-aged French women, 2004–14
Gabet, A., Danchin, N., Juillière, Y., & Olié, V. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx097 · Cited by 144 · see citing works
Kharazmi, E., Dossus, L., Rohrmann, S., & Kaaks, R. (2010) · Heart · doi:10.1136/hrt.2010.202226 · Cited by 143 · see citing works
Haug, E. B., Horn, J., Markovitz, A. R., Fraser, A., Klykken, B., Dalen, H., VATTEN, L. J., Romundstad, P., Rich-Edwards, J. W., & Åsvold, B. O. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.1746 · Cited by 141 · see citing works
Parity and risk of maternal cardiovascular disease: A dose–response meta-analysis of cohort studies
Li, W., Ruan, W., Lu, Z., & Wang, D. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487318818265 · Cited by 139 · see citing works
Gronich, N., Lavi, I., & Rennert, G. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.110463 · Cited by 135 · see citing works
Pollock, M., Fernandes, R. M., Newton, A. S., Scott, S. D., & Hartling, L. (2019) · Systematic Reviews · doi:10.1186/s13643-018-0768-8 · Cited by 132 · see citing works
Wu, P., Gulati, M., Kwok, C., Wong, C., Narain, A., O’Brien, S., Chew-Graham, C. A., Verma, G., Kadam, U., & Mamas, M. A. (2018) · Keele Research Repository (Keele University) · Cited by 132 · see citing works
Lo, C. C. W., Lo, A., Leow, S. H., Fisher, G., Corker, B., Batho, O., Morris, B., Chowaniec, M., Vladutiu, C. J., Fraser, A., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.013991 · Cited by 130 · see citing works
Lindheim, S. R., Buchanan, T. A., Duffy, D. M., Vijod, M. A., Kojima, T., Stanczyk, F. Z., & Løbo, R. A. (1994) · Journal of the Society for Gynecologic Investigation · doi:10.1177/107155769400100210 · Cited by 127 · see citing works
History of preterm birth and subsequent cardiovascular disease: a systematic review
Robbins, C. L., Hutchings, Y., Dietz, P. M., Kuklina, E. V., & Callaghan, W. M. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.09.020 · Cited by 125 · see citing works
Li, J., Song, C., Li, C., Liu, P., Sun, Z., & Yang, X. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.054 · Cited by 124 · see citing works
Glisic, M., Shahzad, S., Tsoli, S., Chadni, M., Asllanaj, E., Rojas, L. Z., Brown, E., Chowdhury, R., Muka, T., & Franco, O. H. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318774847 · Cited by 124 · see citing works
Gallagher, L. G., Davis, L. B., Ray, R. M., Psaty, B. M., Gao, D. L., Checkoway, H., & Thomas, D. B. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr134 · Cited by 121 · see citing works
Savitz, D. A., Danilack, V. A., Elston, B., & Lipkind, H. S. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu118 · Cited by 120 · see citing works
Peters, S. A. E., Yang, L., Guo, Y., Chen, Y., Bian, Z., Du, J., Yang, J., Li, S., Li, L., Woodward, M., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006081 · Cited by 118 · see citing works
Stöckl, D., Meisinger, C., Peters, A., Thorand, B., Huth, C., Heier, M., Rathmann, W., Kowall, B., Stöckl, H., & Döring, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026076 · Cited by 117 · see citing works
Pregnancy Loss and Later Risk of Atherosclerotic Disease
Ranthe, M. F., Andersen, E. A. W., Wohlfahrt, J., Bundgaard, H., Melbye, M., & Boyd, H. A. (2013) · Circulation · doi:10.1161/circulationaha.112.000285 · Cited by 117 · see citing works
Pell, J. P. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh064 · Cited by 108 · see citing works
Combined oral contraceptive use among women with hypertension: a systematic review
Curtis, K. M., Mohllajee, A. P., Martins, S. L., & Peterson, H. B. (2006) · Contraception · doi:10.1016/j.contraception.2005.08.005 · Cited by 108 · see citing works
Heida, K. Y., Velthuis, B. K., Oudijk, M. A., Reitsma, J. B., Bots, M. L., Franx, A., van Dunné, F. M., & on behalf of the Dutch Guideline Development Group on Cardiovascular Risk Management after Reproductive Disorders (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487314566758 · Cited by 100 · see citing works
Methodology for jbi umbrella reviews
Aromataris, E., Fernandez, R. S., Godfrey, C. M., Holly, C. M., Khalil, H., & Tungpunkom, P. (2014) · Research Online (University of Wollongong) · Cited by 96 · see citing works
Cardiovascular Risk Following Fertility Therapy
Dayan, N., Filion, K. B., Okano, M., Kilmartin, C., Reinblatt, S., Landry, T., Basso, O., & Udell, J. A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.753 · Cited by 94 · see citing works
Tehrani, F. R., Amiri, M., Behboudi‐Gandevani, S., Yarandi, R. B., & Carmina, E. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1650337 · Cited by 93 · see citing works
Sheikh, H. U., Pavlovic, J. M., Loder, E., & Burch, R. C. (2017) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13229 · Cited by 90 · see citing works
Auger, N., Luo, Z.-C., Nuyt, A. M., Kaufman, J. S., Naimi, A. I., Platt, R. W., & Fraser, W. D. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.12.011 · Cited by 83 · see citing works
Xu, Z., Li, Y., Tang, S., Huang, X., & Chen, T. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.04.021 · Cited by 80 · see citing works
Lactation and cardiovascular risk factors in mothers in a population-based study: the HUNT-study
Natland, S. T., Nilsen, T. I. L., Midthjell, K., Andersen, L. F., & Forsmo, S. (2012) · International Breastfeeding Journal · doi:10.1186/1746-4358-7-8 · Cited by 80 · see citing works
Parity, breastfeeding and risk of coronary heart disease: A pan-European case–cohort study
Peters, S. A., van der Schouw, Y. T., Wood, A. M., Sweeting, M. J., Moons, K. G., Weiderpass, E., Arriola, L., Benetou, V., Boeing, H., Bonnet, F., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316658571 · Cited by 80 · see citing works
Anderson, S., Barry, J. A., & Hardiman, P. J. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.06.079 · Cited by 77 · see citing works
Nedkoff, L. J., Briffa, T. G., Preen, D. B., Sanfilippo, F. M., Hung, J., Ridout, S. C., Knuiman, M. W., & HOBBS, M. S. T. (2011) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.960005 · Cited by 77 · see citing works
Horton, L. G., Simmons, K. B., & Curtis, K. M. (2016) · Contraception · doi:10.1016/j.contraception.2016.05.014 · Cited by 75 · see citing works
Davis, M. B., Diamond, J. E., Montgomery, D. G., Krishnan, S. M., Eagle, K. A., & Jackson, E. A. (2015) · Clinical Research in Cardiology · doi:10.1007/s00392-015-0827-2 · Cited by 73 · see citing works
Nonoral combined hormonal contraceptives and thromboembolism: a systematic review
Tepper, N. K., Dragoman, M. V., Gaffield, M. E., & Curtis, K. M. (2017) · Contraception · doi:10.1016/j.contraception.2016.10.005 · Cited by 73 · see citing works
Lactation Duration and Midlife Atherosclerosis
Gunderson, E. P., Quesenberry, C. P., Ning, X., Jacobs, D. R., Gross, M., Goff, D. C., Pletcher, M. J., & Lewis, C. E. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000919 · Cited by 72 · see citing works
Parity and Cardiovascular Disease Mortality: a Dose-Response Meta-Analysis of Cohort Studies
Lv, H., Wu, H., Yin, J., Qian, J., & Ge, J. (2015) · Scientific Reports · doi:10.1038/srep13411 · Cited by 72 · see citing works
Lactation and maternal subclinical cardiovascular disease among premenopausal women
McClure, C. K., Catov, J. M., Ness, R. B., & Schwarz, E. B. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.04.030 · Cited by 68 · see citing works
Chen, X., Liu, Y., Sun, X., Yin, Z., Li, H., Liu, X., Zhang, D., Cheng, C., Liu, L., Liu, F., et al. (2019) · Menopause · doi:10.1097/gme.0000000000001289 · Cited by 68 · see citing works
Collins, P., Rosano, G., Casey, C., Daly, C., Gambacciani, M., Hadji, P., Kaaja, R., Mikkola, T., Palacios, S., Preston, R., et al. (2007) · Climacteric · doi:10.1080/13697130701755213 · Cited by 67 · see citing works
Pundir, J., Charles, D., Sabatini, L., Hiam, D., Jitpiriyaroj, S., Teede, H. J., Coomarasamy, A., Moran, L., & Thangaratinam, S. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy045 · Cited by 66 · see citing works
Self-citationZhou, Y., Wang, X., Jiang, Y., Ma, H., Chen, L., Lai, C., Peng, C., He, C., & Sun, C. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1347779 · Cited by 64 · see citing works
Kirkegaard, H., Bliddal, M., Støvring, H., Rasmussen, K. M., Gunderson, E. P., Køber, L., Sørensen, T. I. A., & Nohr, E. A. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2018.06.014 · Cited by 64 · see citing works
Nguyen, B., Gale, J., Nassar, N., Bauman, A., Joshy, G., & Ding, D. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011056 · Cited by 64 · see citing works
Skilton, M. R., Sérusclat, A., Begg, L. M., Moulin, P., & Bonnet, F. (2009) · Stroke · doi:10.1161/strokeaha.108.535807 · Cited by 62 · see citing works
Rosendaal, N. T. A., & Pirkle, C. M. (2017) · BMC Public Health · doi:10.1186/s12889-017-4519-x · Cited by 60 · see citing works
Safety of hormonal contraceptives among women with migraine: A systematic review
Tepper, N. K., Whiteman, M. K., Zapata, L. B., Marchbanks, P. A., & Curtis, K. M. (2016) · Contraception · doi:10.1016/j.contraception.2016.04.016 · Cited by 59 · see citing works
Natland Fagerhaug, T., Forsmo, S., Jacobsen, G. W., Midthjell, K., Andersen, L. F., & Ivar Lund Nilsen, T. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-1070 · Cited by 58 · see citing works
Biochemical Cardiovascular Risk Factors After Hypertensive Pregnancy Disorders
Hermes, W., Ket, J. C. F., van Pampus, M. G., Franx, A., Veenendaal, M. V. E., de Kolster, C. C., Tamsma, J. T., Bloemenkamp, K. W. M., Ponjee, G. A. E., van der Hout, E., et al. (2012) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e31827682fc · Cited by 57 · see citing works
Cardiovascular risk prediction models for women in the general population: A systematic review
Baart, S. J., Dam, V., Scheres, L. J. J., Damen, J. A., Spijker, R., Schuit, E., Debray, T. P. A., Fauser, B. C. J. M., Boersma, E. H., Moons, K. G. M., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210329 · Cited by 56 · see citing works
Pollock, M., Fernandes, R. M., Newton, A. S., Scott, S. D., & Hartling, L. (2019) · Systematic Reviews · doi:10.1186/s13643-018-0914-3 · Cited by 52 · see citing works
Ho, R. S., Wu, X., Yuan, J., Liu, S., Lai, X., Wong, S. Y., & Chung, V. C. (2015) · npj Primary Care Respiratory Medicine · doi:10.1038/npjpcrm.2014.102 · Cited by 50 · see citing works
Smith, G., Wood, A., Pell, J., & Hattie, J. (2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02890.x · Cited by 48 · see citing works
Haddaway, N. R., Land, M., & Macura, B. (2017) · Environment International · doi:10.1016/j.envint.2016.12.020 · Cited by 48 · see citing works
Jacobson, L. T., Hade, E. M., Collins, T. C., Margolis, K. L., Waring, M. E., Van Horn, L. V., Silver, B., Sattari, M., Bird, C. E., Kimminau, K., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008739 · Cited by 44 · see citing works
Dragoman, M., Curtis, K. M., & Gaffield, M. E. (2016) · Contraception · doi:10.1016/j.contraception.2015.08.002 · Cited by 43 · see citing works
Breastfeeding Duration and the Risk of Coronary Artery Disease
Rajaei, S., Rigdon, J., Crowe, S., Tremmel, J., Tsai, S., & Assimes, T. L. (2019) · Journal of Women's Health · doi:10.1089/jwh.2018.6970 · Cited by 43 · see citing works
Hypertension and obesity after the menopause.
RAPPELLI, A. (2002) · PubMed · Cited by 42 · see citing works
Two methods provide similar signals for the need to update systematic reviews
Chung, M. C., Newberry, S. J., Ansari, M. T., Yu, W. W., Wu, H., Lee, J., Suttorp, M. J., Gaylor, J. M., Motala, A., Moher, D., et al. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.12.004 · Cited by 42 · see citing works
Freibert, S. M., Mannino, D. M., Bush, H., & Crofford, L. J. (2011) · Journal of Women's Health · doi:10.1089/jwh.2010.2097 · Cited by 42 · see citing works
Gong, D., Sun, J., Zhou, Y., Zou, C., & Fan, Y. J. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.092 · Cited by 40 · see citing works
Miscarriage and risk of cardiovascular disease
Kharazmi, E., Fallah, M., & Luoto, R. M. (2009) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016340903380758 · Cited by 39 · see citing works
A surveillance system to assess the need for updating systematic reviews
Ahmadzai, N., Newberry, S. J., Maglione, M. A., Tsertsvadze, A., Ansari, M. T., Hempel, S., Motala, A., Tsouros, S., Schneider Chafen, J. J., Shanman, R., et al. (2013) · Systematic Reviews · doi:10.1186/2046-4053-2-104 · Cited by 33 · see citing works
Hopmans, T. E. J. P., van Houten, C. B., Kasius, A., Kouznetsova, O. I., Nguyen, A. L., Rooijmans, S. V., Voormolen, D. N., van Vliet, E. O. G., Franx, A., & Koster, M. P. H. (2015) · PubMed · Cited by 31 · see citing works
Maternal anemia during pregnancy and subsequent risk for cardiovascular disease
Erez Azulay, C., Pariente, G., Shoham-Vardi, I., Kessous, R., Sergienko, R., & Sheiner, E. (2015) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2014.971743 · Cited by 31 · see citing works
Risk of Cardiovascular Events in Mothers of Women with Polycystic Ovary Syndrome
Cheang, K. I., Nestler, J. E., & Futterweit, W. (2008) · Endocrine Practice · doi:10.4158/ep.14.9.1084 · Cited by 31 · see citing works
Grand’Maison, S., Pilote, L., Schlosser, K., Stewart, D. J., Okano, M., & Dayan, N. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.08.025 · Cited by 31 · see citing works
Xu, Z., Yue, Y., Bai, J., Shen, C., Yang, J., Huang, X., Zhao, Y., & Li, Y. (2018) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4723-7 · Cited by 31 · see citing works
Assessing the methodological quality of systematic reviews
Welsh, E. J., Normansell, R., & Cates, C. J. (2015) · npj Primary Care Respiratory Medicine · doi:10.1038/npjpcrm.2015.19 · Cited by 29 · see citing works
Importance of engaging obstetrician/gynecologists in cardiovascular disease prevention
Ehrenthal, D. B., & Catov, J. M. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328364298e · Cited by 24 · see citing works
Chen, P.-C., Tseng, T.-C., Hsieh, J.-Y., & Lin, H.-W. (2011) · Stroke · doi:10.1161/strokeaha.110.612655 · Cited by 23 · see citing works
From Qualitative Reviews to Umbrella Reviews
Ortega, A., Briz, E. L., & Fraga‐Fuentes, M. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-25655-9_3 · Cited by 21 · see citing works
Mahendru, A. A., Everett, T. R., McEniery, C. M., Wilkinson, I. B., & Lees, C. C. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.733774 · Cited by 19 · see citing works
Cardiovascular disease risk unmasked by pregnancy complications
Jasper, R., & Skelding, K. A. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.07.020 · Cited by 19 · see citing works
Reproductive factors in relation to heart failure in women: A systematic review
Bolijn, R., Onland-Moret, N. C., Asselbergs, F. W., & van der Schouw, Y. T. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.09.004 · Cited by 17 · see citing works
Cardiometabolic risk in patients with polycystic ovary syndrome.
Ozegowska, K., & Pawelczyk, L. (2015) · Polish Gynaecology · doi:10.17772/gp/59131 · Cited by 15 · see citing works
Risk of myocardial infarction in women with pelvic inflammatory disease
Liou, T.-H., Wu, C.-W., Hao, W.-R., Hsu, M.-I., Liu, J.-C., & Lin, H.-W. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.01.006 · Cited by 14 · see citing works
Do We Need a Different Approach to Assess Cardiovascular Risk in Women?
Isiadinso, I., & WENGER, N. K. (2017) · US Cardiology Review · doi:10.15420/usc.2016:8:2 · Cited by 13 · see citing works
First trimester bleeding and maternal cardiovascular morbidity
Lykke, J. A., & Langhoff‐Roos, J. (2012) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2012.06.003 · Cited by 10 · see citing works
Pregnancy Characteristics and Women’s Cardiovascular Health
Fraser, A., Catov, J. M., Lawlor, D. A., & Rich-Edwards, J. W. (2017) · Springer eBooks · doi:10.1007/978-3-319-47143-3_8 · Cited by 10 · see citing works
Oliver-Williams, C., Lo, C., Lo, A., Hui, S., Fisher, G., Corker, B., Batho, O., Morris, B., Chowaniec, M., & Fraser, A. (2019) · Stable IHD/Prevention/Hypertension/Lipids · doi:10.1136/heartjnl-2019-bcs.105 · Cited by 5 · see citing works
Understanding Umbrella Review of the Cardiovascular Research
Borges, L. S. R., & Biondi‐Zoccai, G. (2016) · International Journal of Cardiovascular Sciences · doi:10.5935/2359-4802.20160066 · Cited by 2 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- 2019, Heart and circulatory disease statistics 2019, Stat Compend, 2019, 94
Cited by
Sorted by citations
The Impact of Sex and Gender on Stroke
Rexrode, K. M., Madsen, T. E., Yu, A., Carcel, C., Lichtman, J. H., & Miller, E. C. (2022) · Circulation Research · doi:10.1161/circresaha.121.319915 · Cited by 609 · see citing works
Magee, L. A., Nicolaides, K. H., & von Dadelszen, P. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2109523 · Cited by 588 · see citing works
Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women
O’Kelly, A. C., Michos, E. D., SHUFELT, C. L., Vermunt, J. V., Minissian, M., Quesada, O., Smith, G. N., Rich-Edwards, J. W., Garovic, V. D., Khoudary, S. R. E., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.319895 · Cited by 344 · see citing works
Wong, N. D., Budoff, M. J., Ferdinand, K. C., Graham, I. M., Michos, E. D., Reddy, T. K., Shapiro, M. D., & Toth, P. P. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100335 · Cited by 316 · see citing works
Menopause: a cardiometabolic transition
Nappi, R. E., Chedraui, P., Lambrinoudaki, I. V., & Simoncini, T. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00076-6 · Cited by 277 · see citing works
Watts, G. F., Gidding, S. S., Hegele, R. A., Raal, F. J., Sturm, A. C., Jones, L. K., Sarkies, M., Al‐Rasadi, K., Blom, D. J., Daccord, M., et al. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00892-0 · Cited by 257 · see citing works
Hypertensive disorders of pregnancy
Wu, P., Green, M., & Myers, J. (2023) · BMJ · doi:10.1136/bmj-2022-071653 · Cited by 284 · see citing works
Tschiderer, L., Seekircher, L., Kunutsor, S. K., Peters, S. A. E., O’Keeffe, L. M., & Willeit, P. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.022746 · Cited by 240 · see citing works
Polycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular disease
Guan, C. S., Zahid, S., Minhas, A., Ouyang, P., Vaught, A. “. J., Baker, V. L., & Michos, E. D. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.03.009 · Cited by 207 · see citing works
Davis, M. B., Arendt, K. W., Bello, N. A., Brown, H. L., Briller, J. E., Epps, K., Hollier, L. M., Langen, E. S., Park, K. E., Walsh, M. N., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.02.033 · Cited by 188 · see citing works
Sex differences in lipids: a life course approach
Holven, K. B., & Roeters van Lennep, J. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117270 · Cited by 180 · see citing works
Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women
Honigberg, M. C., Zekavat, S. M., Niroula, A., Griffin, G. K., Bick, A. G., Pirruccello, J. P., Nakao, T., Whitsel, E. A., Farland, L. V., Laurie, C. A., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.051775 · Cited by 146 · see citing works
SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses
Vibholm, L. K., Nielsen, S., Pahus, M. H., Frattari, G. S., Olesen, R., Andersen, R., Monrad, I., Andersen, A., Thomsen, M. M., Konrad, C., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103230 · Cited by 119 · see citing works
Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review
Nelson, S. M., Davis, S. R., Kalantaridou, S., Lumsden, M. A., Panay, N., & Anderson, R. A. (2023) · Human Reproduction Update · doi:10.1093/humupd/dmac045 · Cited by 142 · see citing works
Antibody Responses in COVID-19: A Review
Chvatal‐Medina, M., Cortina, Y. A. M., Grajales, P. J. P., Velilla, P. A., & Rugeles, M. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.633184 · Cited by 137 · see citing works
Pregnancy complications and later life women's health
McNestry, C., Killeen, S. L., Crowley, R. K., & McAuliffe, F. M. (2023) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14523 · Cited by 142 · see citing works
Stroke in Women: A Review Focused on Epidemiology, Risk Factors, and Outcomes
Yoon, C. W., & Bushnell, C. (2023) · Journal of Stroke · doi:10.5853/jos.2022.03468 · Cited by 133 · see citing works
Yin, J.-L., Yang, J., Song, X., Qin, X., Chang, Y.-J., Chen, X., Liu, F.-H., Li, Y.-Z., Xu, H.-L., Wei, Y., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02241-y · Cited by 90 · see citing works
Prioritising the primary prevention of heart failure
Khan, S. S., Berwanger, O., Fiuzat, M., McMurray, J. J. V., Narula, J., Prabhakaran, D., Sliwa, K. S., Tromp, J., & Vaduganathan, M. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01393-5 · Cited by 74 · see citing works
Obesity-associated cardiovascular risk in women: hypertension and heart failure
Faulkner, J. (2021) · Clinical Science · doi:10.1042/cs20210384 · Cited by 69 · see citing works
Liu, M., Zhang, D., Zhou, X., Duan, J., Hu, Y., Zhang, W., Liu, Q., Xu, B., & Zhang, A. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03012-w · Cited by 66 · see citing works
Mediterranean diet and risk of breast cancer: An umbrella review
Torres, C. G., Barrios‐Rodríguez, R., Muñoz-Bravo, C., Toledo, E., Dierssen‐Sotos, T., & Jiménez‐Moleón, J. J. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.02.012 · Cited by 60 · see citing works
Update on sex specific risk factors in cardiovascular disease
Nguyen, A. H., Hurwitz, M., SULLIVAN, S. A., Saad, A. F., Kennedy, J. L. W., & Sharma, G. V. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1352675 · Cited by 61 · see citing works
Ardissino, M., Slob, E. A. W., Carter, P., Rogne, T., Girling, J., Burgess, S., & Ng, F. S. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.027933 · Cited by 58 · see citing works
Wang, Y., Stuart, J. J., Rich-Edwards, J. W., Missmer, S. A., Rexrode, K. M., Farland, L. V., Mukamal, K. J., Nelson, S. M., Solomon, C. G., Fraser, A., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.38513 · Cited by 57 · see citing works
da Silva, J. S., Montagnoli, T. L., Rocha, B., Tacco, M. L. C. A., Marinho, S. C. P., & Zapata‐Sudo, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020525 · Cited by 59 · see citing works
Hong, K., Kim, S. H., Cha, D. H., & Park, H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011202 · Cited by 60 · see citing works
Hormones and neuroplasticity: A lifetime of adaptive responses
Been, L. E., Sheppard, P. A. S., Galea, L. A. M., & Glasper, E. R. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.029 · Cited by 58 · see citing works
Guo, Y., Chen, X., Gong, P., Long, H., Wang, J., Yang, W., & Yao, W. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c00018 · Cited by 54 · see citing works
Menopause transition: a golden age to prevent cardiovascular disease
Nappi, R. E., & Simoncini, T. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00018-8 · Cited by 54 · see citing works
Balestrieri, M., Rucci, P., Amendola, D., Bonizzoni, M., Cerveri, G., Colli, C., Dragogna, F., Ducci, G., Elmo, M. G., Ghio, L., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.697058 · Cited by 53 · see citing works
Gestational Diabetes and Incident Heart Failure: A Cohort Study
Echouffo-Tcheugui, J. B., Guan, J., Retnakaran, R. R., & Shah, B. R. (2021) · Diabetes Care · doi:10.2337/dc21-0552 · Cited by 51 · see citing works
Cardiometabolic health in premature ovarian insufficiency
Stevenson, J. C., Collins, P. D., Hamoda, H., Lambrinoudaki, I. V., Maas, A. H. E. M., Maclaran, K., & Panay, N. (2021) · Climacteric · doi:10.1080/13697137.2021.1910232 · Cited by 54 · see citing works
Fu, R., Li, Y., Li, X., & Jiang, W. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101982 · Cited by 55 · see citing works
Fang, F., Bhoo‐Pathy, N., Brand, J. S., Hedayati, E., Grassmann, F., Zeng, E., Bergh, J. C. S., Bian, W., Ludvigsson, J. F., Hall, P., et al. (2022) · eLife · doi:10.7554/elife.71562 · Cited by 50 · see citing works
Kyriacou, H., Al-Mohammad, A., Muehlschlegel, C., Foster-Davies, L., Bruco, M. E. F., Legard, C., Fisher, G., Simmons-Jones, F., & Oliver‐Williams, C. (2022) · European Heart Journal Open · doi:10.1093/ehjopen/oeac065 · Cited by 51 · see citing works
Steroid sulphatase and its inhibitors: past, present, and future
Foster, P. A. (2021) · Molecules · doi:10.3390/molecules26102852 · Cited by 49 · see citing works
COVID-19: the winter lockdown strategy in five European nations
Warren, G. W., Löfstedt, R. E., & Wardman, J. K. (2021) · Journal of Risk Research · doi:10.1080/13669877.2021.1891802 · Cited by 52 · see citing works
Mulchandani, R., Brown, B. B., Brooks, T. J. G., Semper, A. E., Machin, N. W., Linley, E., Borrow, R., Wyllie, D. H., Taylor-Philips, S., Jones, H. E., et al. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104739 · Cited by 47 · see citing works
Sex and Gender Bias as a Mechanistic Determinant of Cardiovascular Disease Outcomes
Kim, I., Field, T. S., Wan, D., Humphries, K. H., & Sedlak, T. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.09.009 · Cited by 46 · see citing works
Advancements in lead therapeutic phytochemicals polycystic ovary syndrome: A review
Luo, E., Jiang, H., Chen, W., Wang, Y., Tang, M., Guo, W., Diao, H., Cai, N.-Y., Yang, X., Bian, Y., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1065243 · Cited by 50 · see citing works
A hidden problem: peripheral artery disease in women
Kavurma, M. M., Boccanfuso, L. M., Cutmore, C., Passam, F. H., Patel, S., Hennessy, A., Loa, J., Figtree, G. A., Golledge, J., Robinson, D. A., et al. (2023) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcad011 · Cited by 47 · see citing works
Zhang, Y., Yang, H., Long, Y., Zhang, Y., Chen, J., Shi, J., & Chen, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-03662-5 · Cited by 46 · see citing works
Yaow, C. Y. L., Chong, B., Chin, Y. H., Kueh, M. T. W., Ng, C. H., Chan, K. E., Tang, A. S. P., Chung, C. H., Goh, R. J. L., Kong, G., et al. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad133 · Cited by 45 · see citing works
The relationships between women’s reproductive factors: a Mendelian randomisation analysis
Prince, C., Sharp, G. C., Howe, L. D., Fraser, A., & Richmond, R. C. (2022) · BMC Medicine · doi:10.1186/s12916-022-02293-5 · Cited by 41 · see citing works
Liang, C., Chung, H., Dobson, A. J., & Mishra, G. D. (2022) · Stroke · doi:10.1161/strokeaha.121.036271 · Cited by 42 · see citing works
Ngene, N. C., & Moodley, J. (2024) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2024.102473 · Cited by 55 · see citing works
Sadoyu, S., Tanni, K. A., Punrum, N., Paengtrai, S., Kategaew, W., Promchit, N., Lai, N. M., Thakkinstian, A., Ngorsuraches, S., Bangpan, M., et al. (2022) · PLOS ONE · doi:10.1371/journal.pone.0269009 · Cited by 40 · see citing works
Crute, C., Hall, S., Landon, C. D., Garner, A., Everitt, J. I., Zhang, S., Blake, B. E., Olofsson, D., Chen, H., Murphy, S. K., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.156499 · Cited by 40 · see citing works
Wambua, S., Singh, M., Okoth, K., Snell, K. I. E., Riley, R. D., Yau, C., Thangaratinam, S., Nirantharakumar, K., Crowe, F. L., & on behalf of the MuM-PreDiCT Group (2024) · BMC Medicine · doi:10.1186/s12916-024-03284-4 · Cited by 43 · see citing works
Self-citationDiagnostic Utility of Non-invasive Tests for Inflammatory Bowel Disease: An Umbrella Review
Shi, J.-T., Zhang, Y., She, Y., Goyal, H., Wu, Z.-Q., & Xu, H. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.920732 · Cited by 39 · see citing works
Mussa, J., Meltzer, S., Bond, R., Garfield, N., & Dasgupta, K. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041454 · Cited by 38 · see citing works
Jiménez‐Osorio, A. S., Carreón‐Torres, E., Solís, E. C., Angel-García, J., Arias‐Rico, J., Jiménez-Garza, O., Castillejos, L. M., Díaz-Zuleta, H. A., Téllez, R. M. B., Sánchez-Padilla, M. L., et al. (2023) · Antioxidants · doi:10.3390/antiox12101894 · Cited by 37 · see citing works
Society for endocrinology guideline for understanding, diagnosing and treating female hypogonadism
Jayasena, C. N., Devine, K., Barber, K., Comninos, A. N., Conway, G. S., Crown, A. L., Davies, M. C., Ewart, A., Seal, L., Smyth, A., et al. (2024) · Clinical Endocrinology · doi:10.1111/cen.15097 · Cited by 39 · see citing works
Lailler, G., Grave, C., Gabet, A., Joly, P., Regnault, N., Deneux‐Tharaux, C., Tsatsaris, V., Plu‐Bureau, G., Kretz, S., Blacher, J., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.033252 · Cited by 36 · see citing works
Dennison, R. A., Griffin, S. J., Usher‐Smith, J. A., Fox, R. A., Aiken, C., & Meek, C. L. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262852 · Cited by 36 · see citing works
Current and emerging drug treatment strategies for polycystic ovary syndrome
Helvaci, N., & Yildiz, B. O. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2108702 · Cited by 35 · see citing works
Searching for female reproductive aging and longevity biomarkers
Yureneva, S. V., Геннадьевна, А. В., Silachev, D. N., Донников, А. Е., Gavisova, A., Serov, V. N., & Sukhikh, G. T. (2021) · Aging · doi:10.18632/aging.203206 · Cited by 35 · see citing works
Perinatal depression and risk of maternal cardiovascular disease: a Swedish nationwide study
Lu, D., Valdimarsdóttir, U. A., Wei, D., Chen, Y., Andreassen, O. A., Fang, F., László, K. D., & Bränn, E. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae170 · Cited by 33 · see citing works
Sueldo, M. D., Rivera, M. A. M., Sanchez-Zambrano, M. B., Zilberman, J. M., Múnera, A. G., Paniagua, M., Campos-Alcántara, L., Almonte, C., Paix-Gonzales, A., Anchique-Santos, C. V., et al. (2022) · Archivos de cardiología de México · doi:10.24875/acm.22000071 · Cited by 35 · see citing works
Okoth, K., Parry‐Smith, W., Thomas, G. N., Nirantharakumar, K., & Adderley, N. J. (2023) · BMC Medicine · doi:10.1186/s12916-023-02794-x · Cited by 33 · see citing works
Self-citationAssociation between dry eye disease and depression: An umbrella review
Tsai, C., Jiesisibieke, Z. L., & Tung, T. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.910608 · Cited by 33 · see citing works
Feng, W., Wang, X., Huang, D. F., & Lu, A. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1989374 · Cited by 32 · see citing works
Faulkner, J., Wright, D., Antonova, G. N., Jaffe, I. Z., Kennard, S., & de Chantemèle, E. J. B. (2022) · Hypertension · doi:10.1161/hypertensionaha.121.18832 · Cited by 31 · see citing works
A Lifecourse Perspective on Female Sex-Specific Risk Factors for Later Life Cognition
Peterson, A. J., & Tom, S. E. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01133-y · Cited by 32 · see citing works
Broni, E. K., Ndumele, C. E., Echouffo-Tcheugui, J. B., Kalyani, R. R., Bennett, W. L., & Michos, E. D. (2022) · Current Diabetes Reports · doi:10.1007/s11892-021-01444-x · Cited by 32 · see citing works
Louis, J. M., Parchem, J. G., Vaught, A. “. J., Tesfalul, M. A., Kendle, A. M., & Tsigas, E. Z. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.06.038 · Cited by 32 · see citing works
Female sex-specific considerations to improve rigor and reproducibility in cardiovascular research
Chang, D. H., Dumanski, S. M., & Ahmed, S. B. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00462.2022 · Cited by 31 · see citing works
Female Reproductive Factors and Risk of New-Onset Heart Failure
Zhu, F., Qi, H., Bos, M. M., Boersma, E. H., & Kavousi, M. (2023) · JACC Heart Failure · doi:10.1016/j.jchf.2023.02.019 · Cited by 32 · see citing works
Ferritin and iron supplements in gestational diabetes mellitus: less or more?
Li, T., Zhang, J., & Li, P. (2023) · European Journal of Nutrition · doi:10.1007/s00394-023-03250-5 · Cited by 31 · see citing works
Moslehi, N., Zeraattalab-Motlagh, S., Rahimi Sakak, F., Shab-Bidar, S., Tehrani, F. R., & Mirmiran, P. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuac075 · Cited by 28 · see citing works
Role of breastfeeding on maternal and childhood cancers: An umbrella review of meta-analyses
Fan, D., Xia, Q., Lin, D., Ma, Y., Rao, J., Liu, L., Tang, H., Xu, T., Li, P., Chen, G., et al. (2023) · Journal of Global Health · doi:10.7189/jogh.13.04067 · Cited by 28 · see citing works
Zahid, S., Khan, M. Z., Gowda, S. N., Faza, N. N., Honigberg, M. C., Vaught, A. “. J., Guan, C. S., Minhas, A., & Michos, E. D. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.025839 · Cited by 28 · see citing works
Sex Differences in Physical Activity and Incident Stroke: A Systematic Review
Madsen, T. E., Samaei, M., Pikula, A., Yu, A. Y. X., Carcel, C., Millsaps, E., Yalamanchili, R. S., Bencie, N., Dula, A. N., Leppert, M., et al. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.02.006 · Cited by 27 · see citing works
Spousal Concordance of Cardiovascular Risk Factors in Newly Married Couples in China
Retnakaran, R. R., Wen, S. W., Tan, H., Zhou, S., Ye, C., Shen, M., Smith, G. N., & WALKER, M. C. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.40578 · Cited by 27 · see citing works
Polycystic Ovarian Syndrome: a Risk Factor for Cardiovascular Disease
Alvarez, Y. R., Pico, M. G., Ashokprabhu, N. D., Abou-Amro, K., Bailey, S., Pung, E., Oberholster, E., & Quesada, O. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01168-1 · Cited by 26 · see citing works
Chen, X., Liu, X., Li, F., He, H., Li, X., Qin, T., Jiang, B., Chen, Y., Wang, Y., Su, Y., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03463-8 · Cited by 28 · see citing works
Evaluation and management of blood lipids through a woman's life cycle
Sharma, J., McAlister, J., Aggarwal, N. R., Wei, J., Mehta, P. K., Quesada, O., Mattina, D. J., Scott, N. S., Michos, E. D., Mahmoud, Z., et al. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100333 · Cited by 26 · see citing works
Osibogun, O. I., Ogunmoroti, O., Kolade, O. B., Hays, A. G., Okunrintemi, V., Minhas, A., Gulati, M., & Michos, E. D. (2022) · Journal of Women s Health · doi:10.1089/jwh.2021.0608 · Cited by 26 · see citing works
Li, H., Zhang, L., Yang, F., Zhao, R., Li, X., & Li, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1218386 · Cited by 26 · see citing works
Insights on the NF-κB system in polycystic ovary syndrome, attractive therapeutic targets
Tan, W., Zhang, J., Dai, F., Yang, D., Gu, R., Tang, L., Liu, H., & Cheng, Y. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04736-w · Cited by 25 · see citing works
Liao, Z., Fang, Z., Gou, S., Luo, Y., Liu, Y., He, Z., Li, X., Peng, Y., Fu, Z., Li, D., et al. (2022) · BMC Medicine · doi:10.1186/s12916-021-02229-5 · Cited by 25 · see citing works
Bączkowska, M., Kosińska–Kaczyńska, K., Zgliczyńska, M., Brawura-Biskupski-Samaha, R., Rebizant, B., & Ciebiera, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19095148 · Cited by 25 · see citing works
Cai, M., Li, Q., Cao, Y., Huang, Y., Yao, H., Zhao, C., Wang, J., & Zhu, H. F. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176339 · Cited by 24 · see citing works
Okoth, K., Crowe, F. L., Marshall, T. P., Thomas, G. N., Nirantharakumar, K., & Adderley, N. J. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac024 · Cited by 24 · see citing works
Self-citationKim, M. S., Kim, J. Y., Song, Y. S., Hong, S., Won, H., Kim, W. J., Kwon, Y., Ha, J., Fiedorowicz, J. G., Solmi, M., et al. (2023) · Obesity Reviews · doi:10.1111/obr.13670 · Cited by 23 · see citing works
Research Progress on the Etiology and Treatment of Premature Ovarian Insufficiency
Wang, Y., Jiang, J., Zhang, J., Fan, P., & Xu, J. (2023) · Biomedicine Hub · doi:10.1159/000535508 · Cited by 25 · see citing works
Umbrella reviews: a useful study design in need of standardisation
Shi, X., & Wallach, J. D. (2022) · BMJ · doi:10.1136/bmj.o1740 · Cited by 23 · see citing works
Cardiovascular contributions to dementia: Examining sex differences and female‐specific factors
Alexander, M. W., Paterson, J., Arvanitakis, Z., Black, S. E., Casaletto, K. B., Christakis, M. K., Einstein, G., Galea, L. A. M., Harwood, L., Kirkham, A. A., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70610 · Cited by 23 · see citing works
Tan, L., Nakanishi, E., & Lee, M. (2021) · Environment International · doi:10.1016/j.envint.2021.106956 · Cited by 21 · see citing works
Hou, L., Li, S., Zhu, S., Qian, Y., Liu, W., Wu, Y., Wu, F., Ji, Y., Song, P., & Rahimi, K. (2023) · Neurology · doi:10.1212/wnl.0000000000206863 · Cited by 21 · see citing works
Mengelkoch, S., Gassen, J., Slavich, G. M., & Hill, S. E. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.10.033 · Cited by 22 · see citing works
The impact of reproductive factors on the metabolic profile of females from menarche to menopause
Clayton, G., Borges, M. C., & Lawlor, D. A. (2024) · Nature Communications · doi:10.1038/s41467-023-44459-6 · Cited by 23 · see citing works
Jeong, S., Yoo, J. E., Jeon, K. H., Han, K., Lee, H., Lee, D., & Shin, D. W. (2023) · BMC Medicine · doi:10.1186/s12916-023-02757-2 · Cited by 20 · see citing works
Reproductive milestones across the lifespan and cardiovascular disease risk in women
Stuenkel, C. A. (2023) · Climacteric · doi:10.1080/13697137.2023.2259793 · Cited by 21 · see citing works
Su, X., Wang, X., Liu, Y., Kong, W., Yan, F., Han, F., Liu, Q., & Shi, Y. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113720 · Cited by 19 · see citing works
Kangasniemi, M. H., Arffman, R. K., Joenväärä, S., Haverinen, A., Luiro, K., Tohmola, T., Renkonen, R., Heikinheimo, O., Tapanainen, J. S., & Piltonen, T. T. (2023) · Human Reproduction · doi:10.1093/humrep/deac250 · Cited by 19 · see citing works
Independent risk factors for placental abruption: a systematic review and meta-analysis
Chen, D., Gao, X., Yang, T., Xing, X., Wang, G., Wang, H., He, R., & Liu, M. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07482-7 · Cited by 19 · see citing works
Feng, Y., Lau, S., Chen, Q., Oyston, C., Groom, K. M., Barrett, C. J., & Chamley, L. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.12.030 · Cited by 19 · see citing works
Lipoprotein Metabolism, Dyslipidemia, and Lipid-Lowering Therapy in Women: A Comprehensive Review
Zimodro, J. M., Mucha, M., Berthold, H. K., & Gouni‐Berthold, I. (2024) · Pharmaceuticals · doi:10.3390/ph17070913 · Cited by 20 · see citing works
- Authors
- Okoth, K., Chandan, J. S., Marshall, T., Thangaratinam, S., Thomas, G. N., Nirantharakumar, K., & Adderley, N. J.
- Affiliations
- University of Birmingham (GB)
- Queen Mary University of London (GB)
- Corresponding author
- Nirantharakumar, Krishnarajah
- ORCID
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2020-10-07
- Volume
- 371
- Pages
- m3502
- ISSN
- 1756-1833 (ISSN-L)
- PMC
- PMC7537472
- OpenAlex
- W3091804242
- Cited by
- 416
- References
- 161
- Citations by year
- 2026: 38 · 2025: 76 · 2024: 81 · 2023: 90 · 2022: 74 · 2021: 55 · 2020: 2
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-10-14)
- Open access
- hybrid
- doi.org
- Licence
- Locations
- BMJ (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by-nc)
- Funders
- National Institute for Health and Care Research (ACF-2018-08-001)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- polycystic ovary syndrome, preeclampsia, preterm birth, gestational diabetes mellitus, premature ovarian insufficiency, early menopause, breastfeeding, combined oral contraceptives, progestin-only contraception, heart failure, ischemic heart disease, stroke, peripheral arterial disease, adverse pregnancy outcomes, cardiovascular risk, women's reproductive health
- MeSH terms
- Systematic Reviews as Topic, Correlation of Data, Cardiovascular Diseases, Female, Fertility, Humans, Pregnancy, Pregnancy Complications, Risk Factors, Meta-Analysis as Topic, Risk Assessment, Reproductive Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review